LSCC Lattice Semiconductor Corp

Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains forward-looking statements that involve estimates, assumptions, risks, and uncertainties. Any statements about our expectations, beliefs, plans, objectives, assumptions, or future events or performance are not historical facts and may be forward-looking. We use words or phrases such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “plan,” "possible," “predict,” “projects,” “may,” “will,” “should,” “continue,” “ongoing,” “future,” “potential,” and similar words or phrases to identify forward-looking statements.

 

Forward-looking statements include, but are not limited to, statements about: our target or expected financial performance and our ability to achieve those results; our expectations related to attracting and retaining key personnel; future impacts of the ongoing military conflicts between Ukraine and Russia, and in the Middle East, and the outbreak of new, or expansion of current, military conflicts or terrorism; the impact of any continuing trade or travel restrictions on the export and import of products between the U.S. and China; the impact of any deterioration in relations between Taiwan and China, and other factors affecting military, political, or economic conditions in Taiwan or elsewhere in Asia; the impact of tariffs, trade sanctions, license requirements or similar actions on our suppliers and customers; the impact of inflationary pressures; future impacts of global pandemics, epidemics, and other public health problems; our business strategy; our opportunities to increase our addressable market; our expectations and strategies regarding market trends and opportunities, including market drivers such as wireless and wireline communications infrastructure deployments, data center servers and networking equipment, client computing platforms, industrial Internet of Things, factory automation, robotics, automotive electronics, smart homes, prosumers, and other applications; our expectations regarding the growth of AI-related revenue; our expectations regarding our customer base and the impacts of our customers’ actions on our business; our expectations regarding both new and existing product offerings; our gross margin growth and our strategies to achieve gross margin growth and other financial results; our future investments in research and development; future financial results or accounting treatments; our judgments involved in accounting matters, including revenue recognition, inventories and cost of revenue, and income taxes; actions we may take regarding the design and continued effectiveness of our internal controls over financial reporting; our use of cash; our beliefs regarding the adequacy of our liquidity, capital resources and facilities; whether we will consider and act upon acquisition opportunities to extend our product, technology and product offerings, and the impact of such opportunities on our business; our expectations regarding taxes, including unrecognized tax benefits, and tax adjustments and allowances; whether we will pursue future stock repurchases and how any future repurchases will be funded; the future price volatility of our stock and the effects of that volatility; our ability to prevent and respond to information technology system failures, security breaches and incidents, cyber-attacks or fraud, and the occurrence and impact of such cybersecurity incidents; the costs of mitigating cybersecurity risks; the impact of artificial intelligence ("AI"); the impact of laws and regulations addressing privacy, data protection, and cybersecurity and our ability to comply with the same; our ability to comply with other laws and regulations, the costs of such compliance, and costs incurred if we fail to comply with such laws and regulations; and our beliefs regarding legal or administrative proceedings.

 

These forward-looking statements are based on estimates and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those statements expressed in the forward-looking statements. The key factors, among others, that could cause our actual results to differ materially from the forward-looking statements include global economic conditions and uncertainty, including as a result of trade-related restrictions or tariffs, inflationary pressures, or the effect of any downturn in the economy on capital markets and credit markets; the effects of global military conflicts, pandemics or widespread global health problems and the actions by governments, businesses, and individuals in response to the situation, the effects of which may give rise to or amplify the risks associated with many of these factors listed here; our ability to attract and retain key personnel; and other factors more fully described herein or that are otherwise described from time to time in our filings with the Securities and Exchange Commission ("SEC"), including, but not limited to, the items discussed in Part I, Item 1A, “Risk Factors,” in our Annual Report on Form 10-K for the fiscal year ended December 30, 2023 filed with the SEC on February 16, 2024 and any additional or updated risk factors discussed in any subsequent Quarterly Report on Form 10-Q filed since that date.

 

You should not unduly rely on forward-looking statements because our actual results could differ materially from those expressed by us. In addition, any forward-looking statement applies only as of the date of this filing. We do not plan to, and undertake no obligation to, update any forward-looking statements to reflect new information or new events, circumstances or developments, or otherwise.

 

 

 

PART I. FINANCIAL INFORMATION

---

 

ITEM 1. FINANCIAL STATEMENTS

 

LATTICE SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)

---

 

 

 

See Accompanying Notes to Unaudited Consolidated Financial Statements.

 

 

LATTICE SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(unaudited)

---

 

 

 

See Accompanying Notes to Unaudited Consolidated Financial Statements.

 

 

LATTICE SEMICONDUCTOR CORPORATION

CONSOLIDATED BALANCE SHEETS

(unaudited)

---

 

 

 

See Accompanying Notes to Unaudited Consolidated Financial Statements.

 

 

LATTICE SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

---

 

 

 

See Accompanying Notes to Unaudited Consolidated Financial Statements.

 

 

LATTICE SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(unaudited)

---

 

 

The following summarizes the changes in total equity for the six-month period ended June 29, 2024:

 

 

 

 

 

The following summarizes the changes in total equity for the six-month period ended July 1, 2023:

 

 

 

See Accompanying Notes to Unaudited Consolidated Financial Statements.

 

 

LATTICE SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (continued)

(unaudited)

---

 

 

The following summarizes the changes in total equity for the three-month period ended June 29, 2024:

 

 

 

 

 

The following summarizes the changes in total equity for the three-month period ended July 1, 2023:

 

 

 

See Accompanying Notes to Unaudited Consolidated Financial Statements.

 

 

LATTICE SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

---

 

Note 1 - Basis of Presentation

 

Lattice Semiconductor Corporation and its subsidiaries (“Lattice,” the “Company,” “we,” “us,” or “our”) develop technologies that we monetize through differentiated programmable logic semiconductor products, silicon-enabling products, system solutions, design services, and technology licenses.

 

Basis of Presentation and Use of Estimates

 

The accompanying Consolidated Financial Statements are unaudited and have been prepared in accordance with U.S. Generally Accepted Accounting Principles ("U.S. GAAP") and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). In our opinion, they include all adjustments, consisting only of normal recurring adjustments, necessary for the fair presentation of results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted as permitted by the SEC's rules and regulations for interim reporting. These Consolidated Financial Statements should be read in conjunction with our audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 30, 2023 ("2023 10-K").

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments affecting the amounts reported in our consolidated condensed financial statements and the accompanying notes. We base our estimates and judgments on historical experience, knowledge of current conditions, and our beliefs of what could occur in the future considering available information. While we believe that our estimates, assumptions, and judgments are reasonable, they are based on information available when made, and because of the uncertainty inherent in these matters, the actual results that we experience may differ materially from these estimates under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis.

 

We describe our accounting methods and practices in more detail in our 2023 10-K. There have been no changes to the significant accounting policies, procedures, or general information described in our 2023 10-K that have had a material impact on our consolidated financial statements and related notes. Certain prior year balances have been reclassified to conform to the current year’s presentation.

 

Fiscal Reporting Periods

 

We report based on a 52 or 53-week fiscal year ending on the Saturday closest to December 31. Our fiscal 2024 will be a 52-week year and will end on December 28, 2024, and our fiscal 2023 was a 52-week year that ended December 30, 2023. Our second quarter of fiscal 2024 and second quarter of fiscal 2023 ended on June 29, 2024 and July 1, 2023, respectively. All references to quarterly financial results are references to the results for the relevant 13-week or 26-week fiscal period.

 

Concentrations of Risk

 

Potential exposure to concentrations of risk may impact revenue and accounts receivable. Distributors have historically accounted for a significant portion of our total revenue. Revenue attributable to distributors as a percentage of total revenue was 91% and 89% for the second quarters of fiscal 2024 and 2023, respectively and 89% and 88% for the first six months of fiscal 2024 and 2023, respectively. Distributors also account for a substantial portion of our net accounts receivable. Our three largest distributors accounted for 44%, 29%, and 12% of net accounts receivable at June 29, 2024 and 36%, 29%, and 18% of net accounts receivable at December 30, 2023.

 

Note 2 - Net Income per Share

 

Our calculation of the diluted share count includes the number of shares from our equity awards with market conditions or performance conditions that would be issuable under the terms of such awards at the end of the reporting period. For equity awards with a market condition, the number of shares included in the diluted share count as of the end of each period presented is determined by measuring the achievement of the market condition as of the end of the respective reporting periods. For equity awards with a performance condition, the number of shares that qualified for vesting as of the end of each period presented are included in the diluted share count when the condition for their issuance was satisfied by the end of the respective reporting periods. See "Note 9 - Stock-Based Compensation" to our consolidated financial statements for further discussion of our equity awards with market conditions or performance conditions.

 

- 10 -

---

Table of Contents

 

A summary of basic and diluted Net income per share is presented in the following table:

 

		Three Months Ended								Six Months Ended
		June 29,				July 1,				June 29,				July 1,
(In thousands, except per share data)		2024				2023				2024				2023
Net income		$	22,631			$	50,644			$	37,427			$	106,567
Shares used in basic Net income per share			137,548				137,735				137,480				137,573
Dilutive effect of stock options, RSUs, ESPP shares, and equity awards with a market condition or performance condition			695				2,033				1,005				2,393
Shares used in diluted Net income per share			138,243				139,768				138,485				139,966
Basic Net income per share		$	0.16			$	0.37			$	0.27			$	0.77
Diluted Net income per share		$	0.16			$	0.36			$	0.27			$	0.76

 

The computation of diluted Net income per share excludes the effects of stock options, restricted stock units ("RSUs"), Employee Stock Purchase Plan ("ESPP") shares, and equity awards with a market condition or performance condition that are antidilutive, aggregating approximately the following number of shares:

 

		Three Months Ended								Six Months Ended
		June 29,				July 1,				June 29,				July 1,
(In thousands)		2024				2023				2024				2023
Stock options, RSUs, ESPP shares, and equity awards with a market condition or performance condition excluded as they are antidilutive			1,001				158				898				115

 

Note 3 - Revenue from Contracts with Customers

 

Disaggregation of Revenue

 

The following tables provide information about revenue from contracts with customers disaggregated by channel and by geographical market, based on ship-to location of our customers:

 

		Three Months Ended																Six Months Ended
Revenue by Channel		June 29,								July 1,								June 29,								July 1,
(In thousands)		2024								2023								2024								2023
Distributors		$	112,530				91	%		$	169,362				89	%		$	235,735				89	%		$	330,708				88	%
Direct			11,546				9	%			20,717				11	%			29,156				11	%			43,681				12	%
Total revenue		$	124,076				100	%		$	190,079				100	%		$	264,891				100	%		$	374,389				100	%
Revenue by Geographical Market
(In thousands)
China		$	48,159				39	%		$	55,834				30	%		$	105,031				40	%		$	111,556				30	%
Japan			23,161				19	%			38,728				20	%			48,149				18	%			68,745				18	%
Other Asia			11,299				9	%			24,461				13	%			21,867				8	%			44,477				12	%
Asia			82,619				67	%			119,023				63	%			175,047				66	%			224,778				60	%
Americas			23,609				19	%			32,668				17	%			55,589				21	%			74,571				20	%
Europe			17,848				14	%			38,388				20	%			34,255				13	%			75,040				20	%
Total revenue		$	124,076				100	%		$	190,079				100	%		$	264,891				100	%		$	374,389				100	%

 

- 11 -

---

Table of Contents

 

Contract Balances

 

Our contract assets relate to our rights to consideration for licenses and royalties due to us as a member of the HDMI Founders consortium. The balance results primarily from the amount of estimated revenue related to HDMI that we have recognized to date, but which has not yet been distributed to us by the HDMI licensing agent. Contract assets are included in Prepaid expenses and other current assets on our Consolidated Balance Sheets. The following table summarizes activity during the first six months of fiscal 2024:

 

(In thousands)
Contract assets as of December 30, 2023		$	11,194
Revenues recorded during the period			7,646
Transferred to Accounts receivable or collected			(4,663	)
Contract assets as of June 29, 2024		$	14,177

 

Contract liabilities are included in Accrued liabilities on our Consolidated Balance Sheets. The following table summarizes activity during the first six months of fiscal 2024:

 

(In thousands)
Contract liabilities as of December 30, 2023		$	5,304
Accruals for estimated future stock rotation and scrap returns			9,576
Less: Release of accruals for recognized stock rotation and scrap returns			(8,929	)
Contract liabilities as of June 29, 2024		$	5,951

 

Note 4 - Balance Sheet Components

 

Accounts Receivable

 

Accounts receivable do not bear interest and are shown net of an allowance for expected lifetime credit losses, which reflects our best estimate of probable losses inherent in the accounts receivable balance, as described in our 2023 10-K.

 

		June 29,				December 30,
(In thousands)		2024				2023
Accounts receivable		$	103,442			$	104,373
Less: Allowance for credit losses			—				—
Accounts receivable, net of allowance for credit losses		$	103,442			$	104,373

 

Inventories

 

		June 29,				December 30,
(In thousands)		2024				2023
Work in progress		$	69,659			$	65,396
Finished goods			31,897				33,430
Total inventories, net		$	101,556			$	98,826

 

Property and Equipment – Geographic Information

 

Our Property and equipment, net by country at the end of each period was as follows:

 

		June 29,				December 30,
(In thousands)		2024				2023
United States		$	31,833			$	29,467
Taiwan			8,146				10,222
Philippines			5,153				4,602
China			2,758				2,778
Other			2,911				2,477
Total foreign property and equipment, net			18,968				20,079
Total property and equipment, net		$	50,801			$	49,546

 

- 12 -

---

Table of Contents

 

Accrued Liabilities

 

Included in Accrued liabilities in the Consolidated Balance Sheets are the following balances:

 

		June 29,				December 30,
(In thousands)		2024				2023
Liability for non-cancelable contracts		$	8,977			$	11,418
Current portion of operating lease liabilities			7,249				5,571
Contract liabilities			5,951				5,304
Foreign, VAT, and other taxes payable			3,909				6,758
Other accrued liabilities			6,002				6,997
Total accrued liabilities		$	32,088			$	36,048

 

Note 5 - Long-Term Debt

 

On September 1, 2022, we entered into an Amended and Restated Credit Agreement (the “2022 Credit Agreement”), which provides for a five-year secured revolving loan facility with an aggregate principal amount of up to $350 million.

 

The revolving loans under the 2022 Credit Agreement may be repaid and reborrowed at our discretion, with any remaining outstanding principal amount due and payable on the maturity date of the revolving loan on September 1, 2027. At June 29, 2024 and December 30, 2023, we had no borrowings outstanding under the 2022 Credit Agreement, as we paid off the outstanding balance of our revolving loans during the third quarter of fiscal 2023.

 

We pay a quarterly commitment fee of 0.20% on the unused portion of the revolving facility. Interest expense related to our long-term debt was included in Interest expense on our Consolidated Statements of Operations as follows:

 

		Three Months Ended								Six Months Ended
		June 29,				July 1,				June 29,				July 1,
(In thousands)		2024				2023				2024				2023
Contractual interest		$	-			$	832			$	-			$	2,618
Amortization of original issuance discount and debt costs			67				67				133				133
Total interest expense related to long-term debt		$	67			$	899			$	133			$	2,751

 

- 13 -

---

Table of Contents

Note 6 - Restructuring

 

Under the Q3 2023 Plan, which is described in the 2023 10-K, we incurred restructuring costs of approximately $2.7 million and approximately $5.0 million during the second quarter and first six months, respectively, of fiscal 2024. Under this plan, approximately $7.0 million of total costs have been incurred through June 29, 2024. The Q3 2023 plan is expected to be largely complete by the end of fiscal year 2024.

 

Other restructuring activity in the periods presented consisted of expense adjustments on previous plans. Costs and adjustments on restructuring plans are recorded to Restructuring on our Consolidated Statements of Operations. The restructuring accrual balance is presented in Accrued liabilities and in Other long-term liabilities on our Consolidated Balance Sheets. The following table displays the activity related to our restructuring plans:

 

(In thousands)		Severance & Related (1)				Lease Termination & Fixed Assets				Other (2)				Total
Accrued Restructuring at December 30, 2023		$	1,490			$	4,508			$	620			$	6,618
Restructuring			5,001				(98	)			(620	)			4,283
Costs paid or otherwise settled			(3,713	)			(652	)			—				(4,365	)
Accrued Restructuring at June 29, 2024		$	2,778			$	3,758			$	—			$	6,536
Accrued Restructuring at December 31, 2022		$	400			$	5,892			$	640			$	6,932
Restructuring			(135	)			49				4				(82	)
Costs paid or otherwise settled			(265	)			(721	)			(24	)			(1,010	)
Accrued Restructuring at July 1, 2023		$	—			$	5,220			$	620			$	5,840

 

(1)	Includes employee relocation and outplacement costs
(2)	Includes termination fees on the cancellation of certain contracts

 

Note 7 - Leases

 

We have operating leases for corporate offices, sales offices, research and development facilities, storage facilities, and a data center. All of our facilities are leased under operating leases, which expire at various times through 2029, with a weighted-average remaining lease term of 3.2 years and a weighted-average discount rate of 6.0% as of June 29, 2024.

 

We recorded fixed operating lease expenses of $2.2 million and $1.9 million for the second quarter of fiscal 2024 and 2023, respectively, and $4.3 million and $3.8 million for the first six months of fiscal 2024 and 2023, respectively.

 

The following table presents the lease balance classifications within the Consolidated Balance Sheets and summarizes their activity during the first six months of fiscal 2024:

 

Operating lease right-of-use assets		(In thousands)
Balance as of December 30, 2023		$	14,487
Right-of-use assets obtained for new lease contracts during the period			7,162
Amortization of right-of-use assets during the period			(3,812	)
Impairment of right-of use asset during the period (recorded in Restructuring charges)			(384	)
Adjustments for present value and foreign currency effects			(127	)
Balance as of June 29, 2024		$	17,326

 

Operating lease liabilities		(In thousands)
Balance as of December 30, 2023		$	16,310
Lease liabilities incurred for new lease contracts during the period			7,162
Accretion of lease liabilities			526
Operating cash used for payments on lease liabilities			(4,564	)
Adjustments for present value and foreign currency effects			(210	)
Balance as of June 29, 2024			19,224
Less: Current portion of operating lease liabilities (included in Accrued liabilities)			(7,249	)
Long-term operating lease liabilities, net of current portion		$	11,975

 

- 14 -

---

Table of Contents

 

Maturities of operating lease liabilities as of June 29, 2024 are as follows:

 

Fiscal year		(In thousands)
2024 (Remaining 2 quarters)		$	4,270
2025			6,744
2026			4,580
2027			2,804
2028			2,226
Thereafter			446
Total lease payments			21,070
Less: amount representing interest			(1,846	)
Total lease liabilities		$	19,224

 

Lease obligations for facilities restructured prior to the adoption of Topic 842 totaled approximately $3.8 million at June 29, 2024 and is recorded in Accrued liabilities and in Other long-term liabilities on our Consolidated Balance Sheets.

 

Note 8 - Intangible Assets

 

In connection with our past acquisitions, we have recorded identifiable intangible assets. On our Consolidated Balance Sheets at June 29, 2024 and December 30, 2023, Intangible assets, net are shown net of accumulated amortization of $147.1 million and $144.9 million, respectively. Additionally, we enter into license agreements for third-party technology and record them as intangible assets. These licenses are being amortized to Research and development expense over their estimated useful lives.

 

We recorded amortization expense related to intangible assets on the Consolidated Statements of Operations as presented in the following table:

 

		Three Months Ended								Six Months Ended
		June 29,				July 1,				June 29,				July 1,
(In thousands)		2024				2023				2024				2023
Research and development		$	247			$	271			$	513			$	541
Amortization of acquired intangible assets			869				869				1,739				1,739
		$	1,116			$	1,140			$	2,252			$	2,280

 

Note 9 - Stock-Based Compensation

 

Total stock-based compensation expense included in our Consolidated Statements of Operations is presented in the following table:

 

		Three Months Ended								Six Months Ended
		June 29,				July 1,				June 29,				July 1,
(In thousands)		2024				2023				2024				2023
Cost of revenue		$	800			$	1,414			$	1,655			$	2,367
Research and development			5,865				7,647				13,963				12,986
Selling, general, and administrative			(3,446	)			12,428				6,095				20,391
Total stock-based compensation		$	3,219			$	21,489			$	21,713			$	35,744

 

Market-Based and Performance-Based Stock Compensation

 

In the first quarter of fiscal 2024, we granted awards of RSUs with a market condition to certain executives. Under the terms of these grants, the RSUs with a market condition vest after a three-year period based on the Company’s total shareholder return ("TSR") relative to the Russell 3000 index, which condition is measured for the grants on the third anniversary of the grant date. The awards may vest at 250% or 200%, depending on the executive, if the 75th percentile of the market condition is achieved, with 100% of the units vesting at the 55th percentile, zero vesting if relative TSR is below the 25th percentile, and vesting scaling for achievement between the 25th and 75th percentile.

 

- 15 -

---

Table of Contents

 

In the second quarter of fiscal 2024, we also granted awards of RSUs with a performance condition to certain executives. Under the terms of these grants, the RSUs with a performance condition will vest if the Company achieves year-over-year revenue growth in excess of an industry benchmark, and the number of shares vested will scale for achievement of year-over-year revenue growth compared to certain targets, with maximum vesting up to 250%. The performance condition will be measured annually after each fiscal year-end for one-fourth of the grants beginning in fiscal 2025 through the end of fiscal 2028. Vesting of these awards occurs 13 months after the end of each measurement period and the entire award cannot be fully earned until five and a half years from grant date.

 

In the first six months of fiscal 2024, certain awards with a market condition or performance condition granted in prior fiscal years vested. During the first quarter of fiscal 2024, the market condition for awards granted to certain executives in the first quarter of fiscal 2021 exceeded the 75th percentile of their TSR condition, and these awards vested at 250% or 200%, as applicable for the respective executive. Also during the first quarter of fiscal 2024, the second tranche of awards granted in fiscal 2021 and 2022 with a performance condition vested. Under the terms of these grants, the RSUs with a performance condition will vest based on the Company generating specified levels of year-over-year revenue growth, which are measured annually for one-fourth of the grants after each fiscal year-end through the end of fiscal 2024, with vesting of each tranche occurring 13 months after the performance condition is met. Vesting of these awards scales for achievement of year-over-year revenue growth compared to certain targets, with maximum vesting up to 200%. The second tranche of these awards vested at the 200% level of achievement, as the Company met the maximum year-over-year revenue growth performance criteria as of December 31, 2022. For the third tranche of these awards, the Company met the year-over-year revenue growth performance criteria at the 116.3% level of achievement as of December 30, 2023.

 

For our awards with a market condition or a performance condition, we recorded benefits from forfeitures of approximately $15.1 million in the second quarter of fiscal 2024 due to executive departures, which was partially offset by stock compensation expense of approximately $6.1 million and $12.0 million in the second quarter and first six months of fiscal 2024, respectively, and we incurred stock compensation expense of approximately $11.0 million and $15.9 million in the second quarter and first six months of fiscal 2023, respectively, which are recorded as components of total stock-based compensation.

 

The following table summarizes the activity for our awards with a market condition or performance condition:

 

(Shares in thousands)		Total
Balance, December 30, 2023			852
Granted			772
Effect of vesting multiplier			284
Vested			(541	)
Canceled			(332	)
Balance, June 29, 2024			1,035

 

Note 10 - Common Stock Repurchase Program

 

 

On November 30, 2023, we announced that our Board of Directors had approved a stock repurchase program pursuant to which up to $250 million of outstanding common stock could be repurchased from time to time (the "2024 Repurchase Program"). The duration of the 2024 Repurchase Program is through December 28, 2024.

 

During the second quarter of fiscal 2024, we repurchased 143,402 shares for $10.0 million, or an average price paid per share of $69.73, under the 2024 Repurchase Program. During the first six months of fiscal 2024, we have repurchased a total of 408,282 shares for $30.0 million, or an average price paid per share of $73.48. All repurchases were open market transactions funded from available working capital. All shares repurchased pursuant to the 2024 Repurchase Program were retired by the end of the second quarter of fiscal 2024. As of June 29, 2024, the remaining portion of the amount authorized for the 2024 Repurchase Program is approximately $220.0 million.

 

- 16 -

---

Table of Contents

Note 11 - Income Taxes

 

We are subject to federal and state income tax as well as income tax in the foreign jurisdictions in which we operate. For the second quarter of fiscal 2024 and 2023, we recorded income tax expense of approximately $1.1 million and $2.4 million, respectively. For the first six months of fiscal 2024 and 2023, we recorded income tax expense of approximately $4.2 million and $5.0 million, respectively. Income taxes for the three- and six-month periods ended June 29, 2024 and July 1, 2023 represent tax at the federal, state, and foreign statutory tax rates in addition to federal tax credits, withholding taxes, excess benefits from stock compensation, as well as other non-deductible items in federal, state, and foreign jurisdictions. The difference between the U.S. federal statutory tax rate of 21% and our effective tax rates for the three and six months ended June 29, 2024 resulted primarily from non-deductible items in federal, state, and foreign jurisdictions, foreign rate differentials, federal tax credits, and the discrete impacts of excess tax benefits from stock compensation and for the three and six months ended July 1, 2023 resulted primarily from U.S. valuation allowance, foreign withholding taxes, foreign rate differentials, and the discrete impacts of excess tax benefits from stock compensation.

 

The portion of our uncertain tax positions (including penalties and interest) recorded as a liability was $22.3 million and $21.9 million at June 29, 2024 and December 30, 2023, respectively, and is included as a component of Other long-term liabilities on our Consolidated Balance Sheets. The resolution of audits or expiration of statute of limitations could reduce our uncertain tax positions. The estimated potential reduction in our uncertain tax positions in the next 12 months is up to $36.0 million.

 

Note 12 - Contingencies

 

Legal Proceedings

 

On or about December 19, 2018, Steven De Jaray, Perienne De Jaray and Darrell Oswald (collectively, the “Plaintiffs”) commenced an action against the Company in the Multnomah County Circuit Court of the State of Oregon, in connection with the sale of certain products by the Company to the Plaintiffs in or around 2008. The Plaintiffs alleged the Company violated the Lanham Act, engaged in negligence, fraud, and breach of contract by failing to disclose to the Plaintiffs the export-controlled status of the subject parts. In January 2019, we removed the action to the United States District Court for the District of Oregon (the “Court”). On May 24, 2023, the Plaintiffs filed a second amended complaint, which added Apex-Micro Manufacturing Corporation (“Apex-Micro”) as a plaintiff and removed the violation of the Lanham Act claim.  The Plaintiffs sought damages of $180 million, punitive damages, and other remedies. On January 18, 2024, the court dismissed the claims against the Company by Ms. De Jaray and Mr. Oswald. The trial for the remaining claims was held from January 30, 2024 to February 15, 2024. On February 13, 2024, the Court granted the Company’s Rule 50 motion in part and entered judgment in the Company’s favor as to all of Mr. De Jaray’s claims and Apex-Micro’s negligence claims. On February 15, 2024, the jury found that the Company was not liable for all outstanding claims and judgment was entered  in favor of the Company. On March 15, 2024, Mr. De Jaray and Apex-Micro filed a Notice of Appeal to the United States Court of Appeals for the Ninth Circuit. On March 18, 2024, Ms. De Jaray filed a separate Notice of Appeal. In response to plaintiff's request for an extension, the plaintiffs’ appeal opening brief is now due October 7, 2024. The Company will file an appeal answering brief.

 

From time to time, we are exposed to certain additional asserted and unasserted potential claims. We review the status of each significant matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we then accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we reassess the potential liability related to pending claims and litigation and may revise estimates.

 

 

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion should be read along with the unaudited consolidated financial statements and notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10-Q, as well as the audited consolidated financial statements and notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations in our 2023 10-K.

 

 

Overview

 

Lattice Semiconductor Corporation and its subsidiaries (“Lattice,” the “Company,” “we,” “us,” or “our”) develop technologies that we monetize through differentiated programmable logic semiconductor products, silicon-enabling products, system solutions, design services, and technology licenses. Lattice is the low power programmable leader. We solve customer problems across the network, from the Edge to the Cloud, in the Communications, Computing, Industrial, Automotive, and Consumer markets. Our technology, long-standing relationships, and commitment to world-class support helps our customers quickly and easily unleash their innovation to create a smart, secure, and connected world.

 

Lattice has focused its strategy on delivering programmable logic products and related solutions based on low power, small size, and ease of use. We also serve our customers with intellectual property ("IP") licensing and various other services. Our product development activities include new proprietary products, advanced packaging, existing product enhancements, software development tools, soft IP, and system solutions for high-growth applications such as Edge Artificial Intelligence, wireless and wireline infrastructure, platform security, and factory automation.

 

 

Critical Accounting Policies and Use of Estimates

 

Critical accounting policies are those that are both most important to the portrayal of a company's financial condition and results of operations, and that require management's most difficult, subjective, and complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. There have been no material changes to the items that we disclosed as our critical accounting policies and estimates in Management's Discussion and Analysis of Financial Condition and Results of Operations in our 2023 10-K.

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments affecting the amounts reported in our consolidated condensed financial statements and the accompanying notes. We base our estimates and judgments on historical experience, knowledge of current conditions, and our beliefs of what could occur in the future considering available information. While we believe that our estimates, assumptions, and judgments are reasonable, they are based on information available when made, and because of the uncertainty inherent in these matters, actual results may differ materially from these estimates under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis.

 

 

Impact of Global Economic Activity on our Business

 

Increased financial market volatility, inflationary pressure, interest rate changes, recessionary concerns, uncertainty in the financial and banking industry, and geopolitical tension continue to impact business globally and may impact our operations by causing disruption to our labor markets and supply chains. The extent to which increased financial market volatility, inflationary pressures, global pandemics, and related uncertainty will impact our business activities will depend on future developments that are highly uncertain and cannot be predicted at this time. Additionally, our business is impacted by the cyclic correction affecting the broader semiconductor industry, which has seen softened demand across our end markets.

 

 

Results of Operations

 

Key elements of our Consolidated Statements of Operations, including as a percentage of revenue, are presented in the following table:

 

		Three Months Ended																Six Months Ended
		June 29,								July 1,								June 29,								July 1,
(In thousands)		2024								2023								2024								2023
Revenue		$	124,076				100.0	%		$	190,079				100.0	%		$	264,891				100.0	%		$	374,389				100.0	%
Gross margin			84,751				68.3				132,561				69.7				180,959				68.3				261,162				69.8
Research and development			38,733				31.2				41,946				22.1				79,324				29.9				77,935				20.8
Selling, general and, administrative			20,005				16.1				36,788				19.4				56,474				21.3				69,366				18.5
Amortization of acquired intangible assets			869				0.7				869				0.5				1,739				0.7				1,739				0.5
Restructuring			2,579				2.1				(112	)			(0.1	)			4,283				1.6				(82	)			(0.0	)
Income from operations		$	22,565				18.2	%		$	53,070				27.9	%		$	39,139				14.8	%		$	112,204				30.0	%

 

Revenue by End Market

 

We sell our products globally to a broad base of customers in three primary end market groups: Communications and Computing, Industrial and Automotive, and Consumer. Across our end markets, our products are increasingly used for Artificial Intelligence ("AI")-related applications, including device usage in AI-optimized servers in data centers, AI-enabled PCs, and AI-enabled robotics and ADAS systems, among others. We also provide IP licensing and services to these end markets.

 

Within these end markets, there are multiple drivers, including:

•	Communications and computing: data center servers and networking equipment, client computing platforms, and wireless and wireline communications infrastructure deployments,
•	Industrial and automotive: factory automation, robotics, automotive electronics, and industrial Internet of Things ("IoT"),
•	Consumer: smart home, prosumer, and other applications.

 

The end market data we use is derived from data provided to us by our distributors and end customers. With a diverse base of customers who may manufacture end products spanning multiple end markets, the assignment of revenue to a specific end market requires the use of judgment. We also recognize certain revenue for which end customers and end markets are not yet known. We assign this revenue first to a specific end market using historical and anticipated usage of the specific products, if possible, and allocate the remainder to the end markets based on either historical usage for each product family or industry application data for certain product types.

 

The following are examples of end market applications for the periods presented:

 

Communications and Computing	Industrial and Automotive	Consumer
Wireless	Security and Surveillance	Cameras
Wireline	Machine Vision	Displays
Data Networking	Industrial Automation	Wearables
Server Computing	Robotics	Televisions
Client Computing	Automotive	Home Theater
Data Storage	Drones

 

 

The composition of our revenue by end market is presented in the following table:

 

		Three Months Ended																Six Months Ended
		June 29,								July 1,								June 29,								July 1,
(In thousands)		2024								2023								2024								2023
Communications and Computing		$	54,528				44.0	%		$	64,220				33.8	%		$	109,147				41.2	%		$	130,565				34.9	%
Industrial and Automotive			58,246				46.9				115,496				60.8				133,511				50.4				223,769				59.8
Consumer			11,302				9.1				10,363				5.4				22,233				8.4				20,055				5.3
Total revenue		$	124,076				100.0	%		$	190,079				100.0	%		$	264,891				100.0	%		$	374,389				100.0	%

 

Revenue from the Communications and Computing end market decreased by 15% for the second quarter of fiscal 2024 compared to the second quarter of fiscal 2023 and decreased by 16% for the first six months of fiscal 2024 compared to the first six months of fiscal 2023 primarily due to weaker demand in telecommunications infrastructure deployments and end customers rebalancing their inventory levels, partially offset by stronger demand in data center applications.

 

Revenue from the Industrial and Automotive end market decreased by 50% for the second quarter of fiscal 2024 compared to the second quarter of fiscal 2023 and decreased by 40% for the first six months of fiscal 2024 compared to the first six months of fiscal 2023 primarily due to softer end market demand and end customers rebalancing their inventory levels.

 

While we do not consider AI applications as a distinct end market, we expect AI-related revenue to grow over the next few years based on the growing pipeline of AI-related design wins.

 

 

Revenue by Geography

 

We have a diverse base of customers where distributors represent a significant portion of our total revenue. Our revenue by geographical market is based on the ship-to location of our customers, which can vary from time to time. Revenue from Asia decreased in the periods presented primarily due to the macroeconomic environment in the region, while revenue from the Americas and Europe decreased due to reduced demand in these regions for our products in the Industrial and Automotive end market.

 

The composition of our revenue by geography is presented in the following table:

 

		Three Months Ended																Six Months Ended
		June 29,								July 1,								June 29,								July 1,
(In thousands)		2024								2023								2024								2023
Asia		$	82,619				66.6	%		$	119,023				62.6	%		$	175,047				66.1	%		$	224,778				60.1	%
Americas			23,609				19.0				32,668				17.2				55,589				21.0				74,571				19.9
Europe			17,848				14.4				38,388				20.2				34,255				12.9				75,040				20.0
Total revenue		$	124,076				100.0	%		$	190,079				100.0	%		$	264,891				100.0	%		$	374,389				100.0	%

 

 

Revenue from Customers

 

We sell our products to independent distributors and directly to customers. Distributors have historically accounted for a significant portion of our total revenue. Revenue attributable to distributors as a percentage of total revenue was 91% and 89% for the second quarter of fiscal 2024 and 2023, respectively, and 89% and 88% for the first six months of fiscal 2024 and 2023, respectively.

 

 

Gross Margin

 

The composition of our Gross margin, including as a percentage of revenue, is presented in the following table:

 

		Three Months Ended								Six Months Ended
		June 29,				July 1,				June 29,				July 1,
(In thousands)		2024				2023				2024				2023
Gross margin		$	84,751			$	132,561			$	180,959			$	261,162
Gross margin percentage			68.3	%			69.7	%			68.3	%			69.8	%

 

Gross margin, as a percentage of revenue, decreased 140 basis points in the second quarter of fiscal 2024 compared to the second quarter of fiscal 2023 and decreased by 150 basis points for the first six months of fiscal 2024 compared to the first six months of fiscal 2023. Reduced margins were primarily due to changes in product mix between the periods presented.

 

 

Operating Expenses

 

Research and Development Expense

 

The composition of our Research and development expense, including as a percentage of revenue, is presented in the following table:

 

		Three Months Ended												Six Months Ended
		June 29,				July 1,								June 29,				July 1,
(In thousands)		2024				2023				% change				2024				2023				% change
Research and development		$	38,733			$	41,946				(7.7	)%		$	79,324			$	77,935				1.8	%
Percentage of revenue			31.2	%			22.1	%							29.9	%			20.8	%

 

Research and development expense includes costs for compensation and benefits, stock-based compensation, engineering wafers, depreciation and amortization, licenses, and outside engineering services. These expenditures are for the design of new products, IP cores, processes, packaging, and software solutions. The decrease in Research and development expense for the second quarter of fiscal2024 compared to the second quarter of fiscal 2023 was due primarily to lower headcount-related costs, including stock-based compensation. The increase in Research and development expense for the first six months of fiscal 2024 compared to the first six months of fiscal 2023 was due primarily to higher depreciation and amortization related to our research and development equipment and tools. We believe that investing in research and development is important to delivering innovative products to our customers.

 

 

Selling, General, and Administrative Expense

 

The composition of our Selling, general, and administrative expense, including as a percentage of revenue, is presented in the following table:

 

		Three Months Ended												Six Months Ended
		June 29,				July 1,								June 29,				July 1,
(In thousands)		2024				2023				% change				2024				2023				% change
Selling, general, and administrative		$	20,005			$	36,788				(45.6	)%		$	56,474			$	69,366				(18.6	)%
Percentage of revenue			16.1	%			19.4	%							21.3	%			18.5	%

 

Selling, general, and administrative expense includes costs for compensation and benefits related to selling, general, and administrative employees, commissions, depreciation, professional and outside services, trade show, and travel expenses. The decrease in Selling, general, and administrative expense for the second quarter and first six months of fiscal 2024 compared to the second quarter and first six months of fiscal 2023 was primarily due to the benefits to stock compensation expense from the forfeiture of equity awards by departing executives, partially offset by other costs such as legal expenses.

 

 

Amortization of Acquired Intangible Assets

 

The composition of our Amortization of acquired intangible assets, including as a percentage of revenue, is presented in the following table:

 

		Three Months Ended												Six Months Ended
		June 29,				July 1,								June 29,				July 1,
(In thousands)		2024				2023				% change				2024				2023				% change
Amortization of acquired intangible assets		$	869			$	869				—	%		$	1,739			$	1,739				—	%
Percentage of revenue			0.7	%			0.5	%							0.7	%			0.5	%

 

Amortization of acquired intangible assets was flat between the second quarter and first six months of fiscal 2024 and the second quarter and first six months of fiscal 2023.

 

 

Restructuring

 

The composition of our Restructuring activity, including as a percentage of revenue, is presented in the following table:

 

		Three Months Ended												Six Months Ended
		June 29,				July 1,								June 29,				July 1,
(In thousands)		2024				2023				% change				2024				2023				% change
Restructuring		$	2,579			$	(112	)			100+%			$	4,283			$	(82	)			100+%
Percentage of revenue			2.1	%			(0.1	)%							1.6	%			(0.0	)%

 

Restructuring activity is generally comprised of expenses resulting from workforce reductions, cancellation of contracts, and consolidation of our facilities. Details of our restructuring plans and expenses incurred under them are discussed in "Note 6 - Restructuring" to our Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q. Restructuring costs increased in the second quarter and first six months of fiscal 2024 compared to the second quarter and first six months of fiscal 2023 primarily due to higher costs in the current year periods for severance as compared to minimal restructuring activity in the prior year periods.

 

 

Interest Income (Expense), net

 

The composition of our Interest expense, net, including as a percentage of revenue, is presented in the following table:

 

		Three Months Ended												Six Months Ended
		June 29,				July 1,								June 29,				July 1,
(In thousands)		2024				2023				% change				2024				2023				% change
Interest income (expense), net		$	933			$	189				100+%			$	2,240			$	(366	)			100+%
Percentage of revenue			0.8	%			0.1	%							0.8	%			(0.1	)%

 

The change in Interest income (expense) for the second quarter and first six months of fiscal 2024 compared to the second quarter and first six months of fiscal 2023 was driven by increased interest income, coupled with decreased interest expense as we paid off the outstanding balance of our long-term debt during the third quarter of fiscal 2023.

 

 

Other Income (Expense), net

 

The composition of our Other income (expense), net, including as a percentage of revenue, is presented in the following table:

 

		Three Months Ended												Six Months Ended
		June 29,				July 1,								June 29,				July 1,
(In thousands)		2024				2023				% change				2024				2023				% change
Other income (expense), net		$	254			$	(176	)			100+%			$	208			$	(271	)			100+%
Percentage of revenue			0.2	%			(0.1	)%							0.1	%			(0.1	)%

 

The change in Other income (expense) for the second quarter and first six months of fiscal 2024 compared to the second quarter and first six months of fiscal 2023 was primarily due to foreign currency effects.

 

 

Income Tax Expense

 

The composition of our Income tax expense is presented in the following table:

 

		Three Months Ended												Six Months Ended
		June 29,				July 1,								June 29,				July 1,
(In thousands)		2024				2023				% change				2024				2023				% change
Income tax (benefit) expense		$	1,121			$	2,439				(54.0	)%		$	4,160			$	5,000				(16.8	)%

 

Our Income tax expense is partially offset by federal tax credits and excess tax benefits from stock-based compensation. The lower income tax expense for the current year periods was primarily due to decreased worldwide income, partially offset by the valuation allowance over the federal deferred tax assets present during 2023.

 

 

Liquidity and Capital Resources

 

The following sections discuss material changes in our financial condition from the end of fiscal 2023, including the effects of changes in our Consolidated Balance Sheets, and the effects of our credit arrangements and contractual obligations on our liquidity and capital resources. There continues to be uncertainty around the extent of market volatility, inflationary pressures, interest rate changes, recessionary concerns, uncertainty in the financial and banking industry, and geopolitical tension, which may impact our liquidity and working capital needs in future periods.

 

We have historically financed our operating and capital resource requirements through cash flows from operations, and from the issuance of long-term debt to fund acquisitions. Cash provided by or used in operating activities will fluctuate from period to period due to fluctuations in operating results, the timing and collection of accounts receivable, and required inventory levels, among other things.

 

We believe that our financial resources, including current cash and cash equivalents, cash flow from operating activities, and our credit facilities, will be sufficient to meet our liquidity and working capital needs through at least the next 12 months. On September 1, 2022, we entered into our 2022 Credit Agreement, as described in "Note 5 - Long-Term Debt" under Part I, Item 1 of this report. As of June 29, 2024, we did not have significant long-term commitments for capital expenditures. For further information on our cash commitments for operating lease liabilities, see "Note 7 - Leases" under Part I, Item 1 of this report.

 

In the future, we may continue to consider acquisition opportunities to further extend our product or technology portfolios and further expand our product offerings. In connection with funding capital expenditures, acquisitions, securing additional wafer supply, increasing our working capital, or other operations, we may seek to obtain equity or additional debt financing. We may also seek to obtain equity or additional debt financing if we experience downturns or cyclical fluctuations in our business that are more severe or longer than we anticipated when determining our current working capital needs.

 

 

Cash and cash equivalents

 

(In thousands)		June 29, 2024				December 30, 2023				$ Change				% Change
Cash and cash equivalents		$	109,216			$	128,317			$	(19,101	)			(14.9	)%

 

As of June 29, 2024, we had Cash and cash equivalents of $109.2 million, of which approximately $43.1 million was held by our foreign subsidiaries. We manage our global cash requirements considering, among other things, (i) available funds among our subsidiaries through which we conduct business, (ii) the geographic location of our liquidity needs, and (iii) the cost to access international cash balances. The repatriation of non-US earnings may require us to withhold and pay foreign income tax on dividends. This should not result in our recording significant additional tax expense as we have accrued expense based on current withholding rates. As of June 29, 2024, we could access all cash held by our foreign subsidiaries without incurring significant additional expense.

 

The net decrease in Cash and cash equivalents of $19.1 million between December 30, 2023 and June 29, 2024 was primarily driven by cash flows from the following activities:

 

 

Operating activities — Cash provided by operating activities results from net income adjusted for certain non-cash items and changes in assets and liabilities. Cash provided by operating activities for the first six months of fiscal 2024 was $51.4 million compared to $115.5 million for the first six months of fiscal 2023. This decrease of $64.1 million was primarily driven by $80.5 million less cash provided by net income adjusted for non-cash items, partially offset by $16.4 million of net changes in working capital, primarily in Accrued liabilities and Accrued payroll obligations.

 

Investing activities — Investing cash flows consist primarily of transactions related to capital expenditures and payments for software and intellectual property licenses. Net cash used by investing activities in the first six months of fiscal 2024 was $18.2 million compared to $17.7 million in the first six months of fiscal 2023.

 

Financing activities — Financing cash flows consist primarily of activity on our long-term debt, repurchases of common stock, tax payments related to the net share settlement of restricted stock units, and proceeds from the exercise of options to acquire common stock. Net cash used by financing activities in the first six months of fiscal 2024 was $51.7 million compared to $139.4 million in the first six months of fiscal 2023. This $87.7 million decrease was due to the following activities. During the first six months of fiscal 2024, we had no balance outstanding on our long-term debt, while during the first six months of fiscal 2023 we made discretionary payments totaling $85.0 million on revolving loans under the 2022 Credit Agreement. During the first six months of fiscal 2024, we repurchased approximately 0.4 million shares of common stock for $30.0 million compared to repurchases in the first six months of fiscal 2023 of approximately 0.2 million shares of common stock for $20.0 million. Payments for tax withholdings on vesting of RSUs partially offset by employee exercises of stock options used net cash flows of $21.7 million in the first six months of fiscal 2024, a decrease of approximately $12.7 million from the net $34.4 million used in the first six months of fiscal 2023.

 

Accounts receivable, net

 

(In thousands)		June 29, 2024				December 30, 2023				$ Change				% Change
Accounts receivable, net		$	103,442			$	104,373			$	(931	)			(0.9	)%
Days sales outstanding			76				56				20

 

Accounts receivable, net as of June 29, 2024 decreased by approximately $0.9 million, or 1%, compared to December 30, 2023. This decrease was due to lower revenue shipments as well as the timing of when our customers want our products. We calculate Days sales outstanding on the basis of a 365-day year as Accounts receivable, net at the end of the quarter divided by sales during the quarter annualized and then multiplied by 365.

 

Inventories

 

(In thousands)		June 29, 2024				December 30, 2023				$ Change				% Change
Inventories		$	101,556			$	98,826			$	2,730				2.8	%
Days of inventory on hand			236				175				61

 

Inventories as of June 29, 2024 increased $2.7 million, or approximately 3%, compared to December 30, 2023 primarily as a result of new product ramps. Days of inventory on hand increased over the period due to lower revenue.

 

The Days of inventory on hand ratio compares the inventory balance at the end of a quarter to the cost of sales in that quarter. We calculate Days of inventory on hand on the basis of a 365-day year as Inventories at the end of the quarter divided by Cost of sales during the quarter annualized and then multiplied by 365.

 

Credit Arrangements

 

On September 1, 2022, we entered into our 2022 Credit Agreement. The details of this arrangement are described in "Note 5 - Long-Term Debt" in the Notes to Consolidated Financial Statements of this Quarterly Report on Form 10-Q.

 

As of June 29, 2024, we had no used or unused credit arrangements beyond the secured revolving loan facility described in the 2022 Credit Agreement.

 

Share Repurchase Program

 

See Part II, Item 2, “Unregistered Sales of Equity Securities and Use of Proceeds,” of this Quarterly Report on Form 10-Q for more information about the share repurchase program.

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in foreign currency exchange rates and interest rates. We assess these risks on a regular basis and have established policies that are designed to protect against the adverse effects of these and other potential exposures. There have been no material changes to either the foreign currency exchange rate risk or interest rate risk previously disclosed in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk," of our 2023 10-K.

 

 

ITEM 4. CONTROLS AND PROCEDURES

 

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

 

In connection with the filing of this Quarterly Report on Form 10-Q, our management, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls were effective as of the end of the period covered by this report.

 

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal controls over financial reporting (as defined in Rules 13a-15(f) under the Exchange Act) that occurred during the second quarter of fiscal 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

Inherent Limitations on Effectiveness of Controls

 

We do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

 

PART II. OTHER INFORMATION

---

 

ITEM 1. LEGAL PROCEEDINGS

 

The information set forth above under "Note 12 - Contingencies - Legal Proceedings" contained in the Notes to Consolidated Financial Statements is incorporated herein by reference.

 

 

ITEM 1A. RISK FACTORS

 

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risk factors associated with our business previously described in Part I, Item 1A, “Risk Factors,” in our 2023 10-K. There have been no material changes in the risk factors included in our 2023 10-K, and this report should be read in conjunction with the risk factors set forth in our 2023 10-K. These risk factors are not the only risks facing our company. Additional risks and uncertainties not presently known to us or that we may currently deem to be immaterial could materially adversely affect our business, financial condition, or operating results, including those related to adverse macroeconomic conditions, such as rising inflation and labor shortages, which may affect demand for our products or increase our product or labor costs, negatively impacting our revenues, gross margins, and overall financial results. If any of these risks occur, our business, financial condition, operating results, and cash flows could be materially adversely affected, and the trading price of our common stock could decline. These factors, together with all of the other information in this Quarterly Report on Form 10-Q, including our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q, should be carefully considered before making an investment decision relating to our common stock.

 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Issuer Purchases of Equity Securities

 

On November 30, 2023, we announced that our Board of Directors had approved a stock repurchase program pursuant to which up to $250 million of outstanding common stock could be repurchased from time to time (the "2024 Repurchase Program"). The duration of the 2024 Repurchase Program is through December 28, 2024. During the second quarter of fiscal 2024, we repurchased 143,402 shares for $10.0 million, or an average price paid per share of $69.73. All repurchases were open market transactions funded from available working capital. All shares repurchased pursuant to the 2024 Repurchase Program were retired by the end of the second quarter of fiscal 2024.

 

The following table contains information regarding our repurchases of our common stock that is registered pursuant to Section 12 of the Securities Exchange Act of 1934 during the second quarter of fiscal 2024.

 

Period		Total Number of Shares Purchased				Average Price Paid per Share				Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (a)				Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs ($M) (b)
March 31, 2024 through April 27, 2024			—			$	—				—			$	230.0
April 28, 2024 through May 25, 2024			143,402			$	69.73				143,402			$	220.0
May 26, 2024 through June 29, 2024			—			$	—				—			$	220.0
Total			143,402			$	69.73				143,402			$	220.0

 

(a)		All repurchases during the quarter were open-market transactions funded from available working capital made under the authorization from our Board of Directors to purchase up to $250.0 million of our common stock announced November 30, 2023.
(b)		As of June 29, 2024, this amount consisted of the remaining portion of the $250.0 million program authorized through December 28, 2024 that was announced November 30, 2023.

 

ITEM 5. OTHER INFORMATION

 

Rule 10b5-1 Trading Plans

 

On May 10, 2024, Esam Elashmawi,  Interim Chief Executive Officer and Chief Marketing and Strategy Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense condition of Rule 10b5-1(c), pursuant to which an estimated aggregate of 47,000 shares of our Common Stock may be sold. The aggregate number of shares sold may differ based on tax withholdings for vesting stock awards, actual market achievement for performance RSUs, and actual number of future shares purchased under the Employee Stock Purchase Plan. The duration of the trading arrangement is until May 9, 2025, or earlier if all transactions under the trading arrangement are completed.

 

 

- 27 -

---

Table of Contents

 

ITEM 6. EXHIBITS

 

Exhibit Number		Description
31.1		Certification of Chief Executive Officer pursuant to the Securities Exchange Act of 1934 Rule 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of Chief Financial Officer pursuant to the Securities Exchange Act of 1934 Rule 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1		Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2		Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		Inline XBRL Instance Document (the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File - formatted in Inline XBRL and included in Exhibit 101

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

	LATTICE SEMICONDUCTOR CORPORATION
	(Registrant)
	/s/ Sherri Luther
	Sherri Luther
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

 

Date: July 30, 2024

 

Exhibit 31.1

 

CERTIFICATION

 

I, Esam Elashmawi, certify that:

 

1.	I have reviewed this Quarterly Report on Form 10-Q of Lattice Semiconductor Corporation;

 

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: July 30, 2024

 

/s/ Esam Elashmawi
Esam Elashmawi
Interim Chief Executive Officer & Chief Strategy and Marketing Officer

Exhibit 31.2

 

CERTIFICATION

 

I, Sherri Luther, certify that:

 

1.	I have reviewed this Quarterly Report on Form 10-Q of Lattice Semiconductor Corporation;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	(c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	(d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: July 30, 2024

 

/s/ Sherri Luther
Sherri Luther
Chief Financial Officer

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Lattice Semiconductor Corporation (the Company) on Form 10-Q for the quarter ended June 29, 2024 (the Report), I, Esam Elashmawi, Interim Chief Executive Officer & Chief Strategy and Marketing Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

A signed original of this written statement has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.

 

 

	/s/ Esam Elashmawi
	Esam Elashmawi
	Interim Chief Executive Officer & Chief Strategy and Marketing Officer

 

Date: July 30, 2024

 

 

Exhibit 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Quarterly Report of Lattice Semiconductor Corporation (the Company) on Form 10-Q for the quarter ended June 29, 2024 (the Report), I, Sherri Luther, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

A signed original of this written statement has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.

 

 

	/s/ Sherri Luther
	Sherri Luther
	Chief Financial Officer

 

Date: July 30, 2024

 

 

 

v3.24.2

Document And Entity Information - shares	6 Months Ended
	Jun. 29, 2024	Jul. 23, 2024
Document Information [Line Items]
Entity Central Index Key	0000855658
Entity Registrant Name	Lattice Semiconductor Corp
Amendment Flag	false
Current Fiscal Year End Date	--12-28
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 29, 2024
Document Transition Report	false
Entity File Number	000-18032
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	93-0835214
Entity Address, Address Line One	5555 NE Moore Court
Entity Address, City or Town	Hillsboro
Entity Address, State or Province	OR
Entity Address, Postal Zip Code	97124
City Area Code	503
Local Phone Number	268-8000
Title of 12(b) Security	Common Stock, $.01 par value
Trading Symbol	LSCC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		137,772,234

v3.24.2

Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Revenue	$ 124,076	$ 190,079	$ 264,891	$ 374,389
Cost of revenue	39,325	57,518	83,932	113,227
Gross margin	84,751	132,561	180,959	261,162
Operating expenses:
Research and development	38,733	41,946	79,324	77,935
Selling, general, and administrative	20,005	36,788	56,474	69,366
Amortization of acquired intangible assets	869	869	1,739	1,739
Restructuring	2,579	(112)	4,283	(82)
Total operating expenses	62,186	79,491	141,820	148,958
Income from operations	22,565	53,070	39,139	112,204
Interest income (expense), net	933	189	2,240	(366)
Other income (expense), net	254	(176)	208	(271)
Income before income taxes	23,752	53,083	41,587	111,567
Income tax expense	1,121	2,439	4,160	5,000
Net income	$ 22,631	$ 50,644	$ 37,427	$ 106,567
Net income per share:
Basic (in dollars per share)	$ 0.16	$ 0.37	$ 0.27	$ 0.77
Diluted (in dollars per share)	$ 0.16	$ 0.36	$ 0.27	$ 0.76
Shares used in per share calculations:
Basic (in shares)	137,548	137,735	137,480	137,573
Diluted (in shares)	138,243	139,768	138,485	139,966

v3.24.2

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Net income	$ 22,631	$ 50,644	$ 37,427	$ 106,567
Other comprehensive income (loss):
Translation adjustment	(296)	(457)	(770)	(268)
Comprehensive income	$ 22,335	$ 50,187	$ 36,657	$ 106,299

v3.24.2

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 30, 2023
Current assets:
Cash and cash equivalents	$ 109,216	$ 128,317
Accounts receivable, net of allowance for credit losses	103,442	104,373
Inventories, net	101,556	98,826
Prepaid expenses and other current assets	38,990	36,430
Total current assets	353,204	367,946
Property and equipment, less accumulated depreciation	50,801	49,546
Operating lease right-of-use assets	17,326	14,487
Intangible assets, net	19,016	20,974
Goodwill	315,358	315,358
Deferred income taxes	57,329	57,762
Other long-term assets	14,486	14,821
Total assets	827,520	840,894
Liabilities, Current [Abstract]
Accounts payable	34,957	34,487
Accrued Liabilities, Current	32,088	36,048
Accrued payroll obligations	13,239	26,865
Total current liabilities	80,284	97,400
Long-term operating lease liabilities, net of current portion	11,975	10,739
Other long-term liabilities	36,412	40,735
Total liabilities	128,671	148,874
Contingencies (Note 12)
Stockholders' equity:
Preferred stock, $.01 par value, 10,000,000 shares authorized, none issued and outstanding	0	0
Common stock, $.01 par value, 300,000,000 shares authorized; 137,765,000 shares issued and outstanding as of June 29, 2024 and 137,340,000 shares issued and outstanding as of December 30, 2023	1,378	1,373
Additional paid-in capital	515,753	545,586
Retained earnings	185,394	147,967
Accumulated other comprehensive loss	(3,676)	(2,906)
Total stockholders' equity	698,849	692,020
Total liabilities and stockholders' equity	$ 827,520	$ 840,894

v3.24.2

Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 30, 2023
Accumulated depreciation	$ 119,182	$ 125,856
Preferred stock, par value per share (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value per share (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	300,000,000	300,000,000
Common stock, shares issued (in shares)	137,765,000	137,340,000
Common stock, shares outstanding (in shares)	137,765,000	137,340,000

v3.24.2

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023
Cash flows from operating activities:
Net income	$ 37,427	$ 106,567
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	18,385	16,578
Stock-based compensation expense	21,713	35,744
Change in deferred income tax provision	(969)	(882)
Amortization of right-of-use assets	3,812	3,317
Impairment of operating lease right-of-use asset	384	0
Other non-cash adjustments	133	110
Changes in assets and liabilities:
Accounts receivable, net	931	(2,569)
Inventories, net	(2,730)	(1,115)
Prepaid expenses and other assets	(6,717)	(3,657)
Accounts payable	470	(772)
Accrued liabilities	(3,523)	(15,078)
Accrued payroll obligations	(13,626)	(19,045)
Operating lease liabilities, current and long-term portions	(4,248)	(3,740)
Net cash provided by (used in) operating activities	51,442	115,458
Cash flows from investing activities:
Capital expenditures	(10,581)	(11,943)
Cash paid for software and intellectual property licenses	(7,607)	(5,799)
Net cash provided by (used in) investing activities	(18,188)	(17,742)
Cash flows from financing activities:
Restricted stock unit tax withholdings	(26,980)	(39,189)
Proceeds from issuance of common stock	5,246	4,750
Repurchase of common stock	(29,999)	(20,006)
Repayment of long-term debt	0	(85,000)
Net cash provided by (used in) financing activities	(51,733)	(139,445)
Effect of exchange rate change on cash	(622)	(220)
Net increase (decrease) in cash and cash equivalents	(19,101)	(41,949)
Beginning cash and cash equivalents	128,317	145,722
Ending cash and cash equivalents	109,216	103,773
Supplemental disclosure of cash flow information and non-cash investing and financing activities:
Interest paid	0	2,962
Income taxes paid, net of refunds	3,886	6,837
Operating lease payments	4,564	4,082
Accrued purchases of plant and equipment	160	571
Operating lease right-of-use assets obtained in exchange for lease obligations	$ 7,162	$ 393

v3.24.2

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balances (in shares) at Dec. 31, 2022	137,099,000
Balances at Dec. 31, 2022	$ 1,371	$ 599,300	$ (111,094)	$ (2,414)	$ 487,163
Net income	0	0	106,567	0	106,567
Other comprehensive income (loss)	0	0	0	(268)	(268)
Total comprehensive income					106,299
Common stock issued in connection with employee equity incentive plans, net of shares withheld for employee taxes (in shares)	965,000
Common stock issued in connection with employee equity incentive plans, net of shares withheld for employee taxes	$ 9	(34,448)			(34,439)
Stock-based compensation expense	$ 0	35,744	0	0	35,744
Repurchase of common stock (in shares)	(241,000)
Repurchase of common stock	$ (2)	(20,004)	0	0	(20,006)
Balances (in shares) at Jul. 01, 2023	137,823,000
Balances at Jul. 01, 2023	$ 1,378	580,592	(4,527)	(2,682)	574,761
Balances (in shares) at Apr. 01, 2023	137,637,000
Balances at Apr. 01, 2023	$ 1,376	570,994	(55,171)	(2,225)	514,974
Net income	0	0	50,644	0	50,644
Other comprehensive income (loss)	0	0	0	(457)	(457)
Total comprehensive income					50,187
Common stock issued in connection with employee equity incentive plans, net of shares withheld for employee taxes (in shares)	308,000
Common stock issued in connection with employee equity incentive plans, net of shares withheld for employee taxes	$ 3	(1,890)			(1,887)
Stock-based compensation expense	$ 0	21,489	0	0	21,489
Repurchase of common stock (in shares)	(122,000)
Repurchase of common stock	$ (1)	(10,001)	0	0	(10,002)
Balances (in shares) at Jul. 01, 2023	137,823,000
Balances at Jul. 01, 2023	$ 1,378	580,592	(4,527)	(2,682)	$ 574,761
Balances (in shares) at Dec. 30, 2023	137,340,000				137,340,000
Balances at Dec. 30, 2023	$ 1,373	545,586	147,967	(2,906)	$ 692,020
Net income	0	0	37,427	0	37,427
Other comprehensive income (loss)	0	0	0	(770)	(770)
Total comprehensive income					36,657
Common stock issued in connection with employee equity incentive plans, net of shares withheld for employee taxes (in shares)	833,000
Common stock issued in connection with employee equity incentive plans, net of shares withheld for employee taxes	$ 9	(21,743)			(21,734)
Stock-based compensation expense	$ 0	21,713	0	0	21,713
Repurchase of common stock (in shares)	(408,000)
Repurchase of common stock	$ (4)	(29,803)	0	0	$ (29,807)
Balances (in shares) at Jun. 29, 2024	137,765,000				137,765,000
Balances at Jun. 29, 2024	$ 1,378	515,753	185,394	(3,676)	$ 698,849
Balances (in shares) at Mar. 30, 2024	137,538,000
Balances at Mar. 30, 2024	$ 1,375	521,904	162,763	(3,380)	682,662
Net income	0	0	22,631	0	22,631
Other comprehensive income (loss)	0	0	0	(296)	(296)
Total comprehensive income					22,335
Common stock issued in connection with employee equity incentive plans, net of shares withheld for employee taxes (in shares)	370,000
Common stock issued in connection with employee equity incentive plans, net of shares withheld for employee taxes	$ 4	436			440
Stock-based compensation expense	$ 0	3,219	0	0	3,219
Repurchase of common stock (in shares)	(143,000)
Repurchase of common stock	$ (1)	(9,806)	0	0	$ (9,807)
Balances (in shares) at Jun. 29, 2024	137,765,000				137,765,000
Balances at Jun. 29, 2024	$ 1,378	$ 515,753	$ 185,394	$ (3,676)	$ 698,849

v3.24.2

Note 1 - Basis of Presentation	6 Months Ended
	Jun. 29, 2024
Notes to Financial Statements
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]	Note 1 - Basis of Presentation   Lattice Semiconductor Corporation and its subsidiaries (“Lattice,” the “Company,” “we,” “us,” or “our”) develop technologies that we monetize through differentiated programmable logic semiconductor products, silicon-enabling products, system solutions, design services, and technology licenses.   Basis of Presentation and Use of Estimates   The accompanying Consolidated Financial Statements are unaudited and have been prepared in accordance with U.S. Generally Accepted Accounting Principles ("U.S. GAAP") and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). In our opinion, they include all adjustments, consisting only of normal recurring adjustments, necessary for the fair presentation of results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted as permitted by the SEC's rules and regulations for interim reporting. These Consolidated Financial Statements should be read in conjunction with our audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 30, 2023 ("2023 10-K").   The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments affecting the amounts reported in our consolidated condensed financial statements and the accompanying notes. We base our estimates and judgments on historical experience, knowledge of current conditions, and our beliefs of what could occur in the future considering available information. While we believe that our estimates, assumptions, and judgments are reasonable, they are based on information available when made, and because of the uncertainty inherent in these matters, the actual results that we experience may differ materially from these estimates under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis.   We describe our accounting methods and practices in more detail in our 2023 10-K. There have been no changes to the significant accounting policies, procedures, or general information described in our 2023 10-K that have had a material impact on our consolidated financial statements and related notes. Certain prior year balances have been reclassified to conform to the current year’s presentation.   Fiscal Reporting Periods   We report based on a 52 or 53-week fiscal year ending on the Saturday closest to December 31. Our fiscal 2024 will be a 52-week year and will end on December 28, 2024, and our fiscal 2023 was a 52-week year that ended December 30, 2023. Our second quarter of fiscal 2024 and second quarter of fiscal 2023 ended on June 29, 2024 and July 1, 2023, respectively. All references to quarterly financial results are references to the results for the relevant 13-week or 26-week fiscal period.   Concentrations of Risk   Potential exposure to concentrations of risk may impact revenue and accounts receivable. Distributors have historically accounted for a significant portion of our total revenue. Revenue attributable to distributors as a percentage of total revenue was 91% and 89% for the second quarters of fiscal 2024 and 2023, respectively and 89% and 88% for the first six months of fiscal 2024 and 2023, respectively. Distributors also account for a substantial portion of our net accounts receivable. Our three largest distributors accounted for 44%, 29%, and 12% of net accounts receivable at June 29, 2024 and 36%, 29%, and 18% of net accounts receivable at December 30, 2023.

v3.24.2

Note 2 - Net Income Per Share	6 Months Ended
	Jun. 29, 2024
Notes to Financial Statements
Earnings Per Share [Text Block]	Note 2 - Net Income per Share   Our calculation of the diluted share count includes the number of shares from our equity awards with market conditions or performance conditions that would be issuable under the terms of such awards at the end of the reporting period. For equity awards with a market condition, the number of shares included in the diluted share count as of the end of each period presented is determined by measuring the achievement of the market condition as of the end of the respective reporting periods. For equity awards with a performance condition, the number of shares that qualified for vesting as of the end of each period presented are included in the diluted share count when the condition for their issuance was satisfied by the end of the respective reporting periods. See "Note 9 - Stock-Based Compensation" to our consolidated financial statements for further discussion of our equity awards with market conditions or performance conditions.   A summary of basic and diluted Net income per share is presented in the following table:       Three Months Ended     Six Months Ended       June 29,     July 1,     June 29,     July 1,   (In thousands, except per share data)   2024     2023     2024     2023   Net income   $ 22,631     $ 50,644     $ 37,427     $ 106,567                                     Shares used in basic Net income per share     137,548       137,735       137,480       137,573   Dilutive effect of stock options, RSUs, ESPP shares, and equity awards with a market condition or performance condition     695       2,033       1,005       2,393   Shares used in diluted Net income per share     138,243       139,768       138,485       139,966                                     Basic Net income per share   $ 0.16     $ 0.37     $ 0.27     $ 0.77   Diluted Net income per share   $ 0.16     $ 0.36     $ 0.27     $ 0.76     The computation of diluted Net income per share excludes the effects of stock options, restricted stock units ("RSUs"), Employee Stock Purchase Plan ("ESPP") shares, and equity awards with a market condition or performance condition that are antidilutive, aggregating approximately the following number of shares:       Three Months Ended     Six Months Ended       June 29,     July 1,     June 29,     July 1,   (In thousands)   2024     2023     2024     2023   Stock options, RSUs, ESPP shares, and equity awards with a market condition or performance condition excluded as they are antidilutive     1,001       158       898       115

v3.24.2

Note 3 - Revenue From Contracts With Customers	6 Months Ended
	Jun. 29, 2024
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	Note 3 - Revenue from Contracts with Customers   Disaggregation of Revenue   The following tables provide information about revenue from contracts with customers disaggregated by channel and by geographical market, based on ship-to location of our customers:       Three Months Ended     Six Months Ended   Revenue by Channel   June 29,     July 1,     June 29,     July 1,   (In thousands)   2024     2023     2024     2023   Distributors   $ 112,530       91 %   $ 169,362       89 %   $ 235,735       89 %   $ 330,708       88 % Direct     11,546       9 %     20,717       11 %     29,156       11 %     43,681       12 % Total revenue   $ 124,076       100 %   $ 190,079       100 %   $ 264,891       100 %   $ 374,389       100 %                                                                   Revenue by Geographical Market                                                           (In thousands)                                                                 China   $ 48,159       39 %   $ 55,834       30 %   $ 105,031       40 %   $ 111,556       30 % Japan     23,161       19 %     38,728       20 %     48,149       18 %     68,745       18 % Other Asia     11,299       9 %     24,461       13 %     21,867       8 %     44,477       12 % Asia     82,619       67 %     119,023       63 %     175,047       66 %     224,778       60 % Americas     23,609       19 %     32,668       17 %     55,589       21 %     74,571       20 % Europe     17,848       14 %     38,388       20 %     34,255       13 %     75,040       20 % Total revenue   $ 124,076       100 %   $ 190,079       100 %   $ 264,891       100 %   $ 374,389       100 %   Contract Balances   Our contract assets relate to our rights to consideration for licenses and royalties due to us as a member of the HDMI Founders consortium. The balance results primarily from the amount of estimated revenue related to HDMI that we have recognized to date, but which has not yet been distributed to us by the HDMI licensing agent. Contract assets are included in Prepaid expenses and other current assets on our Consolidated Balance Sheets. The following table summarizes activity during the first six months of fiscal 2024:   (In thousands)         Contract assets as of December 30, 2023   $ 11,194   Revenues recorded during the period     7,646   Transferred to Accounts receivable or collected     (4,663 ) Contract assets as of June 29, 2024   $ 14,177     Contract liabilities are included in Accrued liabilities on our Consolidated Balance Sheets. The following table summarizes activity during the first six months of fiscal 2024:   (In thousands)         Contract liabilities as of December 30, 2023   $ 5,304   Accruals for estimated future stock rotation and scrap returns     9,576   Less: Release of accruals for recognized stock rotation and scrap returns     (8,929 ) Contract liabilities as of June 29, 2024   $ 5,951

v3.24.2

Note 4 - Balance Sheet Components	6 Months Ended
	Jun. 29, 2024
Notes to Financial Statements
Supplemental Balance Sheet Disclosures [Text Block]	Note 4 - Balance Sheet Components   Accounts Receivable   Accounts receivable do not bear interest and are shown net of an allowance for expected lifetime credit losses, which reflects our best estimate of probable losses inherent in the accounts receivable balance, as described in our 2023 10-K.       June 29,     December 30,   (In thousands)   2024     2023   Accounts receivable   $ 103,442     $ 104,373   Less: Allowance for credit losses     —       —   Accounts receivable, net of allowance for credit losses   $ 103,442     $ 104,373     Inventories       June 29,     December 30,   (In thousands)   2024     2023   Work in progress   $ 69,659     $ 65,396   Finished goods     31,897       33,430   Total inventories, net   $ 101,556     $ 98,826     Property and Equipment – Geographic Information   Our Property and equipment, net by country at the end of each period was as follows:       June 29,     December 30,   (In thousands)   2024     2023   United States   $ 31,833     $ 29,467                     Taiwan     8,146       10,222   Philippines     5,153       4,602   China     2,758       2,778   Other     2,911       2,477   Total foreign property and equipment, net     18,968       20,079   Total property and equipment, net   $ 50,801     $ 49,546     Accrued Liabilities   Included in Accrued liabilities in the Consolidated Balance Sheets are the following balances:       June 29,     December 30,   (In thousands)   2024     2023   Liability for non-cancelable contracts   $ 8,977     $ 11,418   Current portion of operating lease liabilities     7,249       5,571   Contract liabilities     5,951       5,304   Foreign, VAT, and other taxes payable     3,909       6,758   Other accrued liabilities     6,002       6,997   Total accrued liabilities   $ 32,088     $ 36,048

v3.24.2

Note 5 - Long-term Debt	6 Months Ended
	Jun. 29, 2024
Notes to Financial Statements
Long-Term Debt [Text Block]	Note 5 - Long-Term Debt   On September 1, 2022, we entered into an Amended and Restated Credit Agreement (the “2022 Credit Agreement”), which provides for a five-year secured revolving loan facility with an aggregate principal amount of up to $350 million.   The revolving loans under the 2022 Credit Agreement may be repaid and reborrowed at our discretion, with any remaining outstanding principal amount due and payable on the maturity date of the revolving loan on September 1, 2027. At June 29, 2024 and December 30, 2023, we had no borrowings outstanding under the 2022 Credit Agreement, as we paid off the outstanding balance of our revolving loans during the third quarter of fiscal 2023.   We pay a quarterly commitment fee of 0.20% on the unused portion of the revolving facility. Interest expense related to our long-term debt was included in Interest expense on our Consolidated Statements of Operations as follows:       Three Months Ended     Six Months Ended       June 29,     July 1,     June 29,     July 1,   (In thousands)   2024     2023     2024     2023   Contractual interest   $ -     $ 832     $ -     $ 2,618   Amortization of original issuance discount and debt costs     67       67       133       133   Total interest expense related to long-term debt   $ 67     $ 899     $ 133     $ 2,751

v3.24.2

Note 6 - Restructuring	6 Months Ended
	Jun. 29, 2024
Notes to Financial Statements
Restructuring and Related Activities Disclosure [Text Block]	Note 6 - Restructuring   Under the Q3 2023 Plan, which is described in the 2023 10-K, we incurred restructuring costs of approximately $2.7 million and approximately $5.0 million during the second quarter and first six months, respectively, of fiscal 2024. Under this plan, approximately $7.0 million of total costs have been incurred through June 29, 2024. The Q3 2023 plan is expected to be largely complete by the end of fiscal year 2024.   Other restructuring activity in the periods presented consisted of expense adjustments on previous plans. Costs and adjustments on restructuring plans are recorded to Restructuring on our Consolidated Statements of Operations. The restructuring accrual balance is presented in Accrued liabilities and in Other long-term liabilities on our Consolidated Balance Sheets. The following table displays the activity related to our restructuring plans:   (In thousands)   Severance & Related (1)     Lease Termination & Fixed Assets     Other (2)     Total   Accrued Restructuring at December 30, 2023   $ 1,490     $ 4,508     $ 620     $ 6,618   Restructuring     5,001       (98 )     (620 )     4,283   Costs paid or otherwise settled     (3,713 )     (652 )     —       (4,365 ) Accrued Restructuring at June 29, 2024   $ 2,778     $ 3,758     $ —     $ 6,536                                     Accrued Restructuring at December 31, 2022   $ 400     $ 5,892     $ 640     $ 6,932   Restructuring     (135 )     49       4       (82 ) Costs paid or otherwise settled     (265 )     (721 )     (24 )     (1,010 ) Accrued Restructuring at July 1, 2023   $ —     $ 5,220     $ 620     $ 5,840     (1)  Includes employee relocation and outplacement costs (2)  Includes termination fees on the cancellation of certain contracts

v3.24.2

Note 7 - Leases	6 Months Ended
	Jun. 29, 2024
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	Note 7 - Leases   We have operating leases for corporate offices, sales offices, research and development facilities, storage facilities, and a data center. All of our facilities are leased under operating leases, which expire at various times through 2029, with a weighted-average remaining lease term of 3.2 years and a weighted-average discount rate of 6.0% as of June 29, 2024.   We recorded fixed operating lease expenses of $2.2 million and $1.9 million for the second quarter of fiscal 2024 and 2023, respectively, and $4.3 million and $3.8 million for the first six months of fiscal 2024 and 2023, respectively.   The following table presents the lease balance classifications within the Consolidated Balance Sheets and summarizes their activity during the first six months of fiscal 2024:   Operating lease right-of-use assets   (In thousands)   Balance as of December 30, 2023   $ 14,487   Right-of-use assets obtained for new lease contracts during the period     7,162   Amortization of right-of-use assets during the period     (3,812 ) Impairment of right-of use asset during the period (recorded in Restructuring charges)     (384 ) Adjustments for present value and foreign currency effects     (127 ) Balance as of June 29, 2024   $ 17,326     Operating lease liabilities   (In thousands)   Balance as of December 30, 2023   $ 16,310   Lease liabilities incurred for new lease contracts during the period     7,162   Accretion of lease liabilities     526   Operating cash used for payments on lease liabilities     (4,564 ) Adjustments for present value and foreign currency effects     (210 ) Balance as of June 29, 2024     19,224   Less: Current portion of operating lease liabilities (included in Accrued liabilities)     (7,249 ) Long-term operating lease liabilities, net of current portion   $ 11,975     Maturities of operating lease liabilities as of June 29, 2024 are as follows:   Fiscal year   (In thousands)   2024 (Remaining 2 quarters)   $ 4,270   2025     6,744   2026     4,580   2027     2,804   2028     2,226   Thereafter     446   Total lease payments     21,070   Less: amount representing interest     (1,846 ) Total lease liabilities   $ 19,224     Lease obligations for facilities restructured prior to the adoption of Topic 842 totaled approximately $3.8 million at June 29, 2024 and is recorded in Accrued liabilities and in Other long-term liabilities on our Consolidated Balance Sheets.

v3.24.2

Note 8 - Intangible Assets	6 Months Ended
	Jun. 29, 2024
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	Note 8 - Intangible Assets   In connection with our past acquisitions, we have recorded identifiable intangible assets. On our Consolidated Balance Sheets at June 29, 2024 and December 30, 2023, Intangible assets, net are shown net of accumulated amortization of $147.1 million and $144.9 million, respectively. Additionally, we enter into license agreements for third-party technology and record them as intangible assets. These licenses are being amortized to Research and development expense over their estimated useful lives.   We recorded amortization expense related to intangible assets on the Consolidated Statements of Operations as presented in the following table:       Three Months Ended     Six Months Ended       June 29,     July 1,     June 29,     July 1,   (In thousands)   2024     2023     2024     2023   Research and development   $ 247     $ 271     $ 513     $ 541   Amortization of acquired intangible assets     869       869       1,739       1,739       $ 1,116     $ 1,140     $ 2,252     $ 2,280

v3.24.2

Note 9 - Stock-based Compensation	6 Months Ended
	Jun. 29, 2024
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	Note 9 - Stock-Based Compensation   Total stock-based compensation expense included in our Consolidated Statements of Operations is presented in the following table:       Three Months Ended     Six Months Ended       June 29,     July 1,     June 29,     July 1,   (In thousands)   2024     2023     2024     2023   Cost of revenue   $ 800     $ 1,414     $ 1,655     $ 2,367   Research and development     5,865       7,647       13,963       12,986   Selling, general, and administrative     (3,446 )     12,428       6,095       20,391   Total stock-based compensation   $ 3,219     $ 21,489     $ 21,713     $ 35,744     Market-Based and Performance-Based Stock Compensation   In the first quarter of fiscal 2024, we granted awards of RSUs with a market condition to certain executives. Under the terms of these grants, the RSUs with a market condition vest after a three-year period based on the Company’s total shareholder return ("TSR") relative to the Russell 3000 index, which condition is measured for the grants on the third anniversary of the grant date. The awards may vest at 250% or 200%, depending on the executive, if the 75th percentile of the market condition is achieved, with 100% of the units vesting at the 55th percentile, zero vesting if relative TSR is below the 25th percentile, and vesting scaling for achievement between the 25th and 75th percentile.   In the second quarter of fiscal 2024, we also granted awards of RSUs with a performance condition to certain executives. Under the terms of these grants, the RSUs with a performance condition will vest if the Company achieves year-over-year revenue growth in excess of an industry benchmark, and the number of shares vested will scale for achievement of year-over-year revenue growth compared to certain targets, with maximum vesting up to 250%. The performance condition will be measured annually after each fiscal year-end for one-fourth of the grants beginning in fiscal 2025 through the end of fiscal 2028. Vesting of these awards occurs 13 months after the end of each measurement period and the entire award cannot be fully earned until five and a half years from grant date.   In the first six months of fiscal 2024, certain awards with a market condition or performance condition granted in prior fiscal years vested. During the first quarter of fiscal 2024, the market condition for awards granted to certain executives in the first quarter of fiscal 2021 exceeded the 75th percentile of their TSR condition, and these awards vested at 250% or 200%, as applicable for the respective executive. Also during the first quarter of fiscal 2024, the second tranche of awards granted in fiscal 2021 and 2022 with a performance condition vested. Under the terms of these grants, the RSUs with a performance condition will vest based on the Company generating specified levels of year-over-year revenue growth, which are measured annually for one-fourth of the grants after each fiscal year-end through the end of fiscal 2024, with vesting of each tranche occurring 13 months after the performance condition is met. Vesting of these awards scales for achievement of year-over-year revenue growth compared to certain targets, with maximum vesting up to 200%. The second tranche of these awards vested at the 200% level of achievement, as the Company met the maximum year-over-year revenue growth performance criteria as of December 31, 2022. For the third tranche of these awards, the Company met the year-over-year revenue growth performance criteria at the 116.3% level of achievement as of December 30, 2023.   For our awards with a market condition or a performance condition, we recorded benefits from forfeitures of approximately $15.1 million in the second quarter of fiscal 2024 due to executive departures, which was partially offset by stock compensation expense of approximately $6.1 million and $12.0 million in the second quarter and first six months of fiscal 2024, respectively, and we incurred stock compensation expense of approximately $11.0 million and $15.9 million in the second quarter and first six months of fiscal 2023, respectively, which are recorded as components of total stock-based compensation.   The following table summarizes the activity for our awards with a market condition or performance condition:   (Shares in thousands)   Total   Balance, December 30, 2023     852   Granted     772   Effect of vesting multiplier     284   Vested     (541 ) Canceled     (332 ) Balance, June 29, 2024     1,035

v3.24.2

Note 10 - Common Stock Repurchase Program	6 Months Ended
	Jun. 29, 2024
Notes to Financial Statements
Treasury Stock [Text Block]	Note 10 - Common Stock Repurchase Program     On November 30, 2023, we announced that our Board of Directors had approved a stock repurchase program pursuant to which up to $250 million of outstanding common stock could be repurchased from time to time (the "2024 Repurchase Program"). The duration of the 2024 Repurchase Program is through December 28, 2024.   During the second quarter of fiscal 2024, we repurchased 143,402 shares for $10.0 million, or an average price paid per share of $69.73, under the 2024 Repurchase Program. During the first six months of fiscal 2024, we have repurchased a total of 408,282 shares for $30.0 million, or an average price paid per share of $73.48. All repurchases were open market transactions funded from available working capital. All shares repurchased pursuant to the 2024 Repurchase Program were retired by the end of the second quarter of fiscal 2024. As of June 29, 2024, the remaining portion of the amount authorized for the 2024 Repurchase Program is approximately $220.0 million.

v3.24.2

Note 11 - Income Taxes	6 Months Ended
	Jun. 29, 2024
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 11 - Income Taxes   We are subject to federal and state income tax as well as income tax in the foreign jurisdictions in which we operate. For the second quarter of fiscal 2024 and 2023, we recorded income tax expense of approximately $1.1 million and $2.4 million, respectively. For the first six months of fiscal 2024 and 2023, we recorded income tax expense of approximately $4.2 million and $5.0 million, respectively. Income taxes for the three- and six-month periods ended June 29, 2024 and July 1, 2023 represent tax at the federal, state, and foreign statutory tax rates in addition to federal tax credits, withholding taxes, excess benefits from stock compensation, as well as other non-deductible items in federal, state, and foreign jurisdictions. The difference between the U.S. federal statutory tax rate of 21% and our effective tax rates for the three and six months ended June 29, 2024 resulted primarily from non-deductible items in federal, state, and foreign jurisdictions, foreign rate differentials, federal tax credits, and the discrete impacts of excess tax benefits from stock compensation and for the three and six months ended July 1, 2023 resulted primarily from U.S. valuation allowance, foreign withholding taxes, foreign rate differentials, and the discrete impacts of excess tax benefits from stock compensation.   The portion of our uncertain tax positions (including penalties and interest) recorded as a liability was $22.3 million and $21.9 million at June 29, 2024 and December 30, 2023, respectively, and is included as a component of Other long-term liabilities on our Consolidated Balance Sheets. The resolution of audits or expiration of statute of limitations could reduce our uncertain tax positions. The estimated potential reduction in our uncertain tax positions in the next 12 months is up to $36.0 million.

v3.24.2

Note 12 - Contingencies	6 Months Ended
	Jun. 29, 2024
Notes to Financial Statements
Contingencies Disclosure [Text Block]	Note 12 - Contingencies   Legal Proceedings   On or about December 19, 2018, Steven De Jaray, Perienne De Jaray and Darrell Oswald (collectively, the “Plaintiffs”) commenced an action against the Company in the Multnomah County Circuit Court of the State of Oregon, in connection with the sale of certain products by the Company to the Plaintiffs in or around 2008. The Plaintiffs alleged the Company violated the Lanham Act, engaged in negligence, fraud, and breach of contract by failing to disclose to the Plaintiffs the export-controlled status of the subject parts. In January 2019, we removed the action to the United States District Court for the District of Oregon (the “Court”). On May 24, 2023, the Plaintiffs filed a second amended complaint, which added Apex-Micro Manufacturing Corporation (“Apex-Micro”) as a plaintiff and removed the violation of the Lanham Act claim.  The Plaintiffs sought damages of $180 million, punitive damages, and other remedies. On January 18, 2024, the court dismissed the claims against the Company by Ms. De Jaray and Mr. Oswald. The trial for the remaining claims was held from January 30, 2024 to February 15, 2024. On February 13, 2024, the Court granted the Company’s Rule 50 motion in part and entered judgment in the Company’s favor as to all of Mr. De Jaray’s claims and Apex-Micro’s negligence claims. On February 15, 2024, the jury found that the Company was not liable for all outstanding claims and judgment was entered  in favor of the Company. On March 15, 2024, Mr. De Jaray and Apex-Micro filed a Notice of Appeal to the United States Court of Appeals for the Ninth Circuit. On March 18, 2024, Ms. De Jaray filed a separate Notice of Appeal. In response to plaintiff's request for an extension, the plaintiffs’ appeal opening brief is now due October 7, 2024. The Company will file an appeal answering brief.   From time to time, we are exposed to certain additional asserted and unasserted potential claims. We review the status of each significant matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we then accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we reassess the potential liability related to pending claims and litigation and may revise estimates.

v3.24.2

Insider Trading Arrangements	6 Months Ended
	Jun. 29, 2024 shares
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]	ITEM 5. OTHER INFORMATION   Rule 10b5-1 Trading Plans   On May 10, 2024, Esam Elashmawi,  Interim Chief Executive Officer and Chief Marketing and Strategy Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense condition of Rule 10b5-1(c), pursuant to which an estimated aggregate of 47,000 shares of our Common Stock may be sold. The aggregate number of shares sold may differ based on tax withholdings for vesting stock awards, actual market achievement for performance RSUs, and actual number of future shares purchased under the Employee Stock Purchase Plan. The duration of the trading arrangement is until May 9, 2025, or earlier if all transactions under the trading arrangement are completed.
Trading Arrangement, Securities Aggregate Available Amount	47,000
Trading Arrangement Adoption Date	May 10, 2024
Trading Arrangement, Individual Name	Esam Elashmawi
Trading Arrangement, Individual Title	Interim Chief Executive Officer and Chief Marketing and Strategy Officer
Rule 10b5-1 Arrangement Adopted [Flag]	true
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false
Rule 10b5-1 Arrangement Terminated [Flag]	true
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false
Trading Arrangement Termination Date	May 9, 2025

v3.24.2

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 29, 2024
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation and Use of Estimates   The accompanying Consolidated Financial Statements are unaudited and have been prepared in accordance with U.S. Generally Accepted Accounting Principles ("U.S. GAAP") and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). In our opinion, they include all adjustments, consisting only of normal recurring adjustments, necessary for the fair presentation of results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted as permitted by the SEC's rules and regulations for interim reporting. These Consolidated Financial Statements should be read in conjunction with our audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 30, 2023 ("2023 10-K").   The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments affecting the amounts reported in our consolidated condensed financial statements and the accompanying notes. We base our estimates and judgments on historical experience, knowledge of current conditions, and our beliefs of what could occur in the future considering available information. While we believe that our estimates, assumptions, and judgments are reasonable, they are based on information available when made, and because of the uncertainty inherent in these matters, the actual results that we experience may differ materially from these estimates under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis.   We describe our accounting methods and practices in more detail in our 2023 10-K. There have been no changes to the significant accounting policies, procedures, or general information described in our 2023 10-K that have had a material impact on our consolidated financial statements and related notes. Certain prior year balances have been reclassified to conform to the current year’s presentation.
Fiscal Period, Policy [Policy Text Block]	Fiscal Reporting Periods   We report based on a 52 or 53-week fiscal year ending on the Saturday closest to December 31. Our fiscal 2024 will be a 52-week year and will end on December 28, 2024, and our fiscal 2023 was a 52-week year that ended December 30, 2023. Our second quarter of fiscal 2024 and second quarter of fiscal 2023 ended on June 29, 2024 and July 1, 2023, respectively. All references to quarterly financial results are references to the results for the relevant 13-week or 26-week fiscal period.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Risk   Potential exposure to concentrations of risk may impact revenue and accounts receivable. Distributors have historically accounted for a significant portion of our total revenue. Revenue attributable to distributors as a percentage of total revenue was 91% and 89% for the second quarters of fiscal 2024 and 2023, respectively and 89% and 88% for the first six months of fiscal 2024 and 2023, respectively. Distributors also account for a substantial portion of our net accounts receivable. Our three largest distributors accounted for 44%, 29%, and 12% of net accounts receivable at June 29, 2024 and 36%, 29%, and 18% of net accounts receivable at December 30, 2023.

v3.24.2

Note 2 - Net Income Per Share (Tables)	6 Months Ended
	Jun. 29, 2024
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended     Six Months Ended       June 29,     July 1,     June 29,     July 1,   (In thousands, except per share data)   2024     2023     2024     2023   Net income   $ 22,631     $ 50,644     $ 37,427     $ 106,567                                     Shares used in basic Net income per share     137,548       137,735       137,480       137,573   Dilutive effect of stock options, RSUs, ESPP shares, and equity awards with a market condition or performance condition     695       2,033       1,005       2,393   Shares used in diluted Net income per share     138,243       139,768       138,485       139,966                                     Basic Net income per share   $ 0.16     $ 0.37     $ 0.27     $ 0.77   Diluted Net income per share   $ 0.16     $ 0.36     $ 0.27     $ 0.76       Three Months Ended     Six Months Ended       June 29,     July 1,     June 29,     July 1,   (In thousands)   2024     2023     2024     2023   Stock options, RSUs, ESPP shares, and equity awards with a market condition or performance condition excluded as they are antidilutive     1,001       158       898       115

v3.24.2

Note 3 - Revenue From Contracts With Customers (Tables)	6 Months Ended
	Jun. 29, 2024
Notes Tables
Disaggregation of Revenue [Table Text Block]	Three Months Ended     Six Months Ended   Revenue by Channel   June 29,     July 1,     June 29,     July 1,   (In thousands)   2024     2023     2024     2023   Distributors   $ 112,530       91 %   $ 169,362       89 %   $ 235,735       89 %   $ 330,708       88 % Direct     11,546       9 %     20,717       11 %     29,156       11 %     43,681       12 % Total revenue   $ 124,076       100 %   $ 190,079       100 %   $ 264,891       100 %   $ 374,389       100 %                                                                   Revenue by Geographical Market                                                           (In thousands)                                                                 China   $ 48,159       39 %   $ 55,834       30 %   $ 105,031       40 %   $ 111,556       30 % Japan     23,161       19 %     38,728       20 %     48,149       18 %     68,745       18 % Other Asia     11,299       9 %     24,461       13 %     21,867       8 %     44,477       12 % Asia     82,619       67 %     119,023       63 %     175,047       66 %     224,778       60 % Americas     23,609       19 %     32,668       17 %     55,589       21 %     74,571       20 % Europe     17,848       14 %     38,388       20 %     34,255       13 %     75,040       20 % Total revenue   $ 124,076       100 %   $ 190,079       100 %   $ 264,891       100 %   $ 374,389       100 %
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]	(In thousands)         Contract assets as of December 30, 2023   $ 11,194   Revenues recorded during the period     7,646   Transferred to Accounts receivable or collected     (4,663 ) Contract assets as of June 29, 2024   $ 14,177   (In thousands)         Contract liabilities as of December 30, 2023   $ 5,304   Accruals for estimated future stock rotation and scrap returns     9,576   Less: Release of accruals for recognized stock rotation and scrap returns     (8,929 ) Contract liabilities as of June 29, 2024   $ 5,951

v3.24.2

Note 4 - Balance Sheet Components (Tables)	6 Months Ended
	Jun. 29, 2024
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	June 29,     December 30,   (In thousands)   2024     2023   Accounts receivable   $ 103,442     $ 104,373   Less: Allowance for credit losses     —       —   Accounts receivable, net of allowance for credit losses   $ 103,442     $ 104,373
Schedule of Inventory, Current [Table Text Block]	June 29,     December 30,   (In thousands)   2024     2023   Work in progress   $ 69,659     $ 65,396   Finished goods     31,897       33,430   Total inventories, net   $ 101,556     $ 98,826
Property, Plant and Equipment [Table Text Block]	June 29,     December 30,   (In thousands)   2024     2023   United States   $ 31,833     $ 29,467                     Taiwan     8,146       10,222   Philippines     5,153       4,602   China     2,758       2,778   Other     2,911       2,477   Total foreign property and equipment, net     18,968       20,079   Total property and equipment, net   $ 50,801     $ 49,546
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	June 29,     December 30,   (In thousands)   2024     2023   Liability for non-cancelable contracts   $ 8,977     $ 11,418   Current portion of operating lease liabilities     7,249       5,571   Contract liabilities     5,951       5,304   Foreign, VAT, and other taxes payable     3,909       6,758   Other accrued liabilities     6,002       6,997   Total accrued liabilities   $ 32,088     $ 36,048

v3.24.2

Note 5 - Long-term Debt (Tables)	6 Months Ended
	Jun. 29, 2024
Notes Tables
Interest Income and Interest Expense Disclosure [Table Text Block]	Three Months Ended     Six Months Ended       June 29,     July 1,     June 29,     July 1,   (In thousands)   2024     2023     2024     2023   Contractual interest   $ -     $ 832     $ -     $ 2,618   Amortization of original issuance discount and debt costs     67       67       133       133   Total interest expense related to long-term debt   $ 67     $ 899     $ 133     $ 2,751

v3.24.2

Note 6 - Restructuring (Tables)	6 Months Ended
	Jun. 29, 2024
Notes Tables
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	(In thousands)   Severance & Related (1)     Lease Termination & Fixed Assets     Other (2)     Total   Accrued Restructuring at December 30, 2023   $ 1,490     $ 4,508     $ 620     $ 6,618   Restructuring     5,001       (98 )     (620 )     4,283   Costs paid or otherwise settled     (3,713 )     (652 )     —       (4,365 ) Accrued Restructuring at June 29, 2024   $ 2,778     $ 3,758     $ —     $ 6,536                                     Accrued Restructuring at December 31, 2022   $ 400     $ 5,892     $ 640     $ 6,932   Restructuring     (135 )     49       4       (82 ) Costs paid or otherwise settled     (265 )     (721 )     (24 )     (1,010 ) Accrued Restructuring at July 1, 2023   $ —     $ 5,220     $ 620     $ 5,840

v3.24.2

Note 7 - Leases (Tables)	6 Months Ended
	Jun. 29, 2024
Notes Tables
Lessee, Operating Lease Right-of-Use Assets and Liabilities [Table Text Block]	Operating lease right-of-use assets   (In thousands)   Balance as of December 30, 2023   $ 14,487   Right-of-use assets obtained for new lease contracts during the period     7,162   Amortization of right-of-use assets during the period     (3,812 ) Impairment of right-of use asset during the period (recorded in Restructuring charges)     (384 ) Adjustments for present value and foreign currency effects     (127 ) Balance as of June 29, 2024   $ 17,326   Operating lease liabilities   (In thousands)   Balance as of December 30, 2023   $ 16,310   Lease liabilities incurred for new lease contracts during the period     7,162   Accretion of lease liabilities     526   Operating cash used for payments on lease liabilities     (4,564 ) Adjustments for present value and foreign currency effects     (210 ) Balance as of June 29, 2024     19,224   Less: Current portion of operating lease liabilities (included in Accrued liabilities)     (7,249 ) Long-term operating lease liabilities, net of current portion   $ 11,975
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]	Fiscal year   (In thousands)   2024 (Remaining 2 quarters)   $ 4,270   2025     6,744   2026     4,580   2027     2,804   2028     2,226   Thereafter     446   Total lease payments     21,070   Less: amount representing interest     (1,846 ) Total lease liabilities   $ 19,224

v3.24.2

Note 8 - Intangible Assets (Tables)	6 Months Ended
	Jun. 29, 2024
Notes Tables
Finite-Lived Intangible Assets Amortization Expense [Table Text Block]	Three Months Ended     Six Months Ended       June 29,     July 1,     June 29,     July 1,   (In thousands)   2024     2023     2024     2023   Research and development   $ 247     $ 271     $ 513     $ 541   Amortization of acquired intangible assets     869       869       1,739       1,739       $ 1,116     $ 1,140     $ 2,252     $ 2,280

v3.24.2

Note 9 - Stock-based Compensation (Tables)	6 Months Ended
	Jun. 29, 2024
Notes Tables
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended     Six Months Ended       June 29,     July 1,     June 29,     July 1,   (In thousands)   2024     2023     2024     2023   Cost of revenue   $ 800     $ 1,414     $ 1,655     $ 2,367   Research and development     5,865       7,647       13,963       12,986   Selling, general, and administrative     (3,446 )     12,428       6,095       20,391   Total stock-based compensation   $ 3,219     $ 21,489     $ 21,713     $ 35,744
Share-Based Payment Arrangement, Performance Shares, Outstanding Activity [Table Text Block]	(Shares in thousands)   Total   Balance, December 30, 2023     852   Granted     772   Effect of vesting multiplier     284   Vested     (541 ) Canceled     (332 ) Balance, June 29, 2024     1,035

v3.24.2

Note 1 - Basis of Presentation (Details Textual) - Sell-through Distributors Concentration Risk [Member]	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023	Dec. 30, 2023
Revenue Benchmark [Member] | Distributors [Member]
Concentration Risk, Percentage	91.00%	89.00%	89.00%	88.00%
Accounts Receivable [Member]
Number of Distributors			3
Accounts Receivable [Member] | Large Distributor One [Member]
Concentration Risk, Percentage			44.00%		36.00%
Accounts Receivable [Member] | Large Distributor Two [Member]
Concentration Risk, Percentage			29.00%		29.00%
Accounts Receivable [Member] | Third Largest Distributor [Member]
Concentration Risk, Percentage			12.00%		18.00%

v3.24.2

Note 2 - Net Income Per Share - Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Net income	$ 22,631	$ 50,644	$ 37,427	$ 106,567
Shares used in basic Net income per share (in shares)	137,548	137,735	137,480	137,573
Dilutive effect of stock options, RSUs, ESPP shares, and equity awards with a market condition or performance condition (in shares)	695	2,033	1,005	2,393
Shares used in diluted Net income per share (in shares)	138,243	139,768	138,485	139,966
Basic (in dollars per share)	$ 0.16	$ 0.37	$ 0.27	$ 0.77
Diluted (in dollars per share)	$ 0.16	$ 0.36	$ 0.27	$ 0.76
Stock options, RSUs, ESPP shares, and equity awards with a market condition or performance condition excluded as they are antidilutive (in shares)	1,001	158	898	115

v3.24.2

Note 3 - Revenue From Contracts with Customers - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Revenue	$ 124,076	$ 190,079	$ 264,891	$ 374,389
Percentage of revenue	100.00%	100.00%	100.00%	100.00%
CHINA
Revenue	$ 48,159	$ 55,834	$ 105,031	$ 111,556
Percentage of revenue	39.00%	30.00%	40.00%	30.00%
JAPAN
Revenue	$ 23,161	$ 38,728	$ 48,149	$ 68,745
Percentage of revenue	19.00%	20.00%	18.00%	18.00%
Other Asia [Member]
Revenue	$ 11,299	$ 24,461	$ 21,867	$ 44,477
Percentage of revenue	9.00%	13.00%	8.00%	12.00%
Asia [Member]
Revenue	$ 82,619	$ 119,023	$ 175,047	$ 224,778
Percentage of revenue	67.00%	63.00%	66.00%	60.00%
Americas [Member]
Revenue	$ 23,609	$ 32,668	$ 55,589	$ 74,571
Percentage of revenue	19.00%	17.00%	21.00%	20.00%
Europe [Member]
Revenue	$ 17,848	$ 38,388	$ 34,255	$ 75,040
Percentage of revenue	14.00%	20.00%	13.00%	20.00%
Sales Channel, Through Intermediary [Member] | Product [Member]
Revenue	$ 112,530	$ 169,362	$ 235,735	$ 330,708
Percentage of revenue	91.00%	89.00%	89.00%	88.00%
Sales Channel, Directly to Consumer [Member] | Product [Member]
Revenue	$ 11,546	$ 20,717	$ 29,156	$ 43,681
Percentage of revenue	9.00%	11.00%	11.00%	12.00%

v3.24.2

Note 3 - Revenue From Contracts With Customers - Contract Balance (Details) $ in Thousands	6 Months Ended
	Jun. 29, 2024 USD ($)
Contract assets, balance	$ 11,194
Revenues recorded during the period	7,646
Transferred to Accounts receivable or collected	(4,663)
Contract assets, balance	14,177
Contract liabilities, balance	5,304
Accruals for estimated future stock rotation and scrap returns	9,576
Less: Release of accruals for recognized stock rotation and scrap returns	(8,929)
Contract liabilities, balance	$ 5,951

v3.24.2

Note 4 - Balance Sheet Components - Accounts Receivable (Details) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 30, 2023
Accounts receivable	$ 103,442	$ 104,373
Less: Allowance for credit losses	0	0
Accounts receivable, net of allowance for credit losses	$ 103,442	$ 104,373

v3.24.2

Note 4 - Balance Sheet Components - Inventories (Details) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 30, 2023
Work in progress	$ 69,659	$ 65,396
Finished goods	31,897	33,430
Total inventories, net	$ 101,556	$ 98,826

v3.24.2

Note 4 - Property and Equipment - Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 30, 2023
Property, Plant and Equipment, Net	$ 50,801	$ 49,546
UNITED STATES
Property, Plant and Equipment, Net	31,833	29,467
TAIWAN
Property, Plant and Equipment, Net	8,146	10,222
PHILIPPINES
Property, Plant and Equipment, Net	5,153	4,602
CHINA
Property, Plant and Equipment, Net	2,758	2,778
Other [Member]
Property, Plant and Equipment, Net	2,911	2,477
Foreign Countries [Member]
Property, Plant and Equipment, Net	$ 18,968	$ 20,079

v3.24.2

Note 4 - Balance Sheet Components - Accrued Liabilities (Details) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 30, 2023
Liabilities, Current [Abstract]
Accrued Liabilities, Current	$ 32,088	$ 36,048
Liability for non-cancelable contracts	8,977	11,418
Current portion of operating lease liabilities	$ 7,249	$ 5,571
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]
Contract liabilities	$ 5,951	$ 5,304
Foreign, VAT, and other taxes payable	3,909	6,758
Other accrued liabilities	6,002	6,997
Total accrued liabilities	$ 32,088	$ 36,048

v3.24.2

Note 5 - Long-term Debt (Details Textual) - The 2022 Credit Agreement [Member[ - Revolving Credit Facility [Member] - USD ($) $ in Thousands		6 Months Ended
	Sep. 01, 2022	Jun. 29, 2024	Dec. 30, 2023
Debt Instrument, Term (Year)	5 years
Line of Credit Facility, Maximum Borrowing Capacity	$ 350,000
Long-Term Debt, Gross		$ 0	$ 0
Line of Credit Facility, Commitment Fee Percentage		0.20%

v3.24.2

Note 5 - Long-term Debt - Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Contractual interest	$ 0	$ 832	$ 0	$ 2,618
Amortization of original issuance discount and debt costs	67	67	133	133
Total interest expense related to long-term debt	$ 67	$ 899	$ 133	$ 2,751

v3.24.2

Note 6 - Restructuring (Details Textual) - Q3 2023 Plan [Member] $ in Millions	3 Months Ended	6 Months Ended
	Jun. 29, 2024 USD ($)	Jun. 29, 2024 USD ($)
Restructuring and Related Cost, Incurred Cost	$ 2.7	$ 5.0
Restructuring and Related Cost, Cost Incurred to Date	$ 7.0	$ 7.0

v3.24.2

Note 6 - Restructuring - Activity Related to Restructuring Plans (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Restructuring		$ 2,579	$ (112)	$ 4,283	$ (82)
Employee Severance [Member]
Accrued Restructuring	[1]			1,490	400
Restructuring	[1]			5,001	(135)
Costs paid or otherwise settled	[1]			(3,713)	(265)
Accrued Restructuring	[1]	2,778	0	2,778	0
Lease Termination and Fixed Assets [Member]
Accrued Restructuring				4,508	5,892
Restructuring				(98)	49
Costs paid or otherwise settled				(652)	(721)
Accrued Restructuring		3,758	5,220	3,758	5,220
Software Contracts and Engineering Tools [Member]
Accrued Restructuring	[2]			620	640
Restructuring	[2]			(620)	4
Costs paid or otherwise settled	[2]			0	(24)
Accrued Restructuring	[2]	0	620	0	620
Other Restructuring [Member]
Accrued Restructuring				6,618	6,932
Restructuring				4,283	(82)
Costs paid or otherwise settled				(4,365)	(1,010)
Accrued Restructuring		$ 6,536	$ 5,840	$ 6,536	$ 5,840
[1] Includes employee relocation and outplacement costs [2] Includes termination fees on the cancellation of certain contracts

v3.24.2

Note 7 - Leases (Details Textual) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Operating Lease, Weighted Average Remaining Lease Term (Year)	3 years 2 months 12 days		3 years 2 months 12 days
Operating Lease, Weighted Average Discount Rate, Percent	6.00%		6.00%
Operating Lease, Cost	$ 2.2	$ 1.9	$ 4.3	$ 3.8
Operating Lease Liability for Previously Restructured Facilities	$ 3.8		$ 3.8

v3.24.2

Note 7 - Leases - Lease Balance Classifications Within the Consolidated Balance Sheets and Lease Activity (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Dec. 30, 2023
Balance	$ 14,487
Right-of-use assets obtained for new lease contracts during the period	7,162
Amortization of right-of-use assets during the period	(3,812)	$ (3,317)
Impairment of right-of use asset during the period (recorded in Restructuring charges)	(384)
Adjustments for present value and foreign currency effects	(127)
Balance	17,326
Balance	16,310
Lease liabilities incurred for new lease contracts during the period	7,162
Accretion of lease liabilities	526
Operating cash used for payments on lease liabilities	(4,564)	$ (4,082)
Adjustments for present value and foreign currency effects	(210)
Balance	19,224
Less: Current portion of operating lease liabilities (included in Accrued liabilities)	(7,249)		$ (5,571)
Long-term operating lease liabilities, net of current portion	$ 11,975		$ 10,739

v3.24.2

Note 7 - Leases - Lease Balance Classifications Within the Consolidated Balance Sheets and Lease Activity (Details) (Parentheticals) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 30, 2023
Liabilities, Current [Abstract]
Accrued Liabilities, Current	$ 32,088	$ 36,048
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]

v3.24.2

Note 7 - Leases - Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 30, 2023
2024 (Remaining 2 quarters)	$ 4,270
2025	6,744
2026	4,580
2027	2,804
2028	2,226
Thereafter	446
Total lease payments	21,070
Less: amount representing interest	(1,846)
Total lease liabilities	$ 19,224	$ 16,310

v3.24.2

Note 8 - Intangible Assets (Details Textual) - USD ($) $ in Millions	Jun. 29, 2024	Dec. 30, 2023
Finite-Lived Intangible Assets, Accumulated Amortization	$ 147.1	$ 144.9

v3.24.2

Note 8 - Intangible Assets - Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Amortization of intangible assets	$ 1,116	$ 1,140	$ 2,252	$ 2,280
Research and Development Expense [Member]
Amortization of intangible assets	247	271	513	541
Amortization of Acquired Intangible Assets [Member]
Amortization of intangible assets	$ 869	$ 869	$ 1,739	$ 1,739

v3.24.2

Note 9 - Stock-based Compensation (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Share-Based Payment Arrangement, Expense	$ 3,219	$ 21,489	$ 21,713	$ 35,744
Restricted Stock Units (RSUs) [Member] | Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Of Market Condition Achieved			75.00%
Restricted Stock Units (RSUs) [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Of Market Condition Achieved			75.00%
Restricted Stock Units (RSUs) [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage, Based on Market Conditions			100.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Of Market Condition Achieved			55.00%
Restricted Stock Units (RSUs) [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Of Market Condition Achieved			25.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage			0.00%
Restricted Stock Units (RSUs) [Member] | Minimum [Member] | Executive Officer [Member] | TSR Relative To PHLX Semiconductor Sector Index, 75th Percentile [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage, Based on Market Conditions			250.00%
Restricted Stock Units (RSUs) [Member] | Minimum [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Of Market Condition Achieved			25.00%
Restricted Stock Units (RSUs) [Member] | Maximum [Member] | Executive Officer [Member] | TSR Relative To PHLX Semiconductor Sector Index, 75th Percentile [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage, Based on Market Conditions			200.00%
Restricted Stock Units (RSUs) [Member] | Maximum [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage, Based on Market Conditions	250.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Of Market Condition Achieved			250.00%
Restricted Stock Units (RSUs) [Member] | Maximum [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Of Market Condition Achieved			75.00%
Performance Shares Granted in 2018 [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Of Market Condition Achieved			200.00%
Performance Shares Granted in 2018 [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Of Market Condition Achieved			116.30%
Performance Shares Granted in 2018 [Member] | Minimum [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage, Based on Market Conditions			200.00%
Awards with Market Condition or Performance Condition [Member]
Share-Based Payment Arrangement, Benefit From Forfeitures	$ 15,100
Share-Based Payment Arrangement, Expense	$ 6,100	$ 11,000	$ 12,000	$ 15,900

v3.24.2

Note 9 - Stock-based Compensation - Stock-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Share-Based Payment Arrangement, Expense	$ 3,219	$ 21,489	$ 21,713	$ 35,744
Cost of Sales [Member]
Share-Based Payment Arrangement, Expense	800	1,414	1,655	2,367
Research and Development Expense [Member]
Share-Based Payment Arrangement, Expense	5,865	7,647	13,963	12,986
Selling, General and Administrative Expenses [Member]
Share-Based Payment Arrangement, Expense	$ (3,446)	$ 12,428	$ 6,095	$ 20,391

v3.24.2

Note 9 - Stock-based Compensation - Share Based Compensation Performance Shares Award Outstanding (Details) - Performance Shares [Member] shares in Thousands	6 Months Ended
	Jun. 29, 2024 shares
Balance, Shares (in shares)	852
Granted, Shares (in shares)	772
Effect of vesting multiplier, Shares (in shares)	284
Vested, Shares (in shares)	(541)
Canceled (in shares)	(332)
Balance, Shares (in shares)	1,035

v3.24.2

Note 10 - Common Stock Repurchase Program (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023	Nov. 30, 2023
Stock Repurchased and Retired During Period, Value	$ 9,807	$ 10,002	$ 29,807	$ 20,006
Repurchase Program 2024 [Member]
Share Repurchase Program, Authorized, Amount					$ 250,000
Stock Repurchased and Retired During Period, Shares (in shares)	143,402		408,282
Stock Repurchased and Retired During Period, Value	$ 10,000		$ 30,000
Shares Acquired, Average Cost Per Share (in dollars per share)	$ 69.73		$ 73.48
Share Repurchase Program, Remaining Authorized, Amount	$ 220,000		$ 220,000

v3.24.2

Note 11 - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023	Dec. 30, 2023
Income Tax Expense (Benefit)	$ 1,121	$ 2,439	$ 4,160	$ 5,000
Decrease in Unrecognized Tax Benefits is Reasonably Possible	36,000		36,000
Other Noncurrent Liabilities [Member]
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	$ 22,300		$ 22,300		$ 21,900
Domestic Tax Jurisdiction [Member]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%		21.00%

v3.24.2

Note 12 - Contingencies (Details Textual) $ in Millions	May 24, 2024 USD ($)
Action in Oregon in Connection with Sale of Certain Products [Member]
Loss Contingency, Damages Sought, Value	$ 180

---